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Design and Synthesis of 3’-Oxygen-Modified Cleavable Nucleotide Reversible Terminators  




This dissertation describes the design and synthesis of novel cleavable fluorescent/anchor 
modified nucleotide reversible terminators using 3’-O-dithiomethyl (3’-O-DTM; 3’-O-SS) as a 
linker to directly or indirectly attach a fluorescent reporter to achieve scarless DNA Sequencing 
by Synthesis (SBS). To develop these nucleotide analogues for four-color SBS, two nucleotide 
analogues (3’-O-ROX-SS-dATP and 3’-O-BodipyFL-SS-dTTP) with directly attached fluorescent 
dyes and two other nucleotide analogues with directly attached biotin or trans-cyclooctene (TCO) 
as anchors (3’-O-Biotin-SS-dCTP and 3’-O-TCO-SS-dGTP) were successfully designed and 
synthesized. The nucleotide analogues with a PEG-elongated linker (3’-O-ROX-PEG4-SS-dATP, 
3’-O-BodipyFL-PEG4-SS-dTTP, 3’-O-Biotin-PEG4-SS-dCTP and 3’-O-TCO-PEG4-SS-dGTP) 
were also designed and synthesized to optimize their incorporation efficiency in polymerase 
reactions. In our design, Biotin and TCO were demonstrated to be anchor moieties with high 
efficiency and specificity for binding with fluorescently labeled streptavidin and tetrazine, 
respectively. The DNA extension products produced by polymerase incorporation of 3’-O-Biotin-
SS-dCTP and 3’-O-Biotin-PEG4-SS-dCTP were accurately identified by binding to Cy5-labeled 
streptavidin, while the DNA extension products produced by polymerase incorporation of 3’-O-
TCO-SS-dGTP and 3’-O-TCO-PEG4-SS-dGTP were identified with equal precision by reaction 
with TAMRA-labeled tetrazine. A proof-of-concept experiment was conducted to demonstrate 





Chapter 1 reviews the history of DNA sequencing technique development, with an emphasis 
on the sequencing by synthesis chemistry and the challenges of designing 3’-O-modified 
nucleotides. Chapter 2 delineates the design and synthesis of 3’-O-SS-cleavable 
fluorescent/anchor modified nucleotide reversible terminators and their performance in 
polymerase and cleavage reactions. Chapter 3 describes the tests that have been conducted on the 
new set of nucleotide reversible terminators, and demonstrates that these new nucleotides can be 
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intensity of these four collected signals was identified as the sequence read. The fluorescent signals 
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Chapter 1 Introduction 
 
Deoxyribonucleic acid (DNA) is the storehouse of genetic information, allowing inheritance 
of traits from ancestors, and directs the development and functioning of all living organisms. Genes 
are units of genetic information inside a cell, encoded by sequences of DNA code. Genomics 
research is built on an understanding of DNA at the molecular level, beginning with the seminal 
discoveries of the helical structure and base-pairing of DNA molecules, and has benefited 
enormously from the development of powerful sequencing technologies for proteins and nucleic 
acids. The completion of the Human Genome Project (HGP) [1] was a remarkable milestone of 
genomics at the beginning of the 21st century. The deciphering of the human genetic code has 
advanced our knowledge of the molecular mechanisms underlying biology, and resulted in many 
applications, such as the emerging personalized medicine paradigm. 
 
The vigorous development of DNA sequencing technology based on Sanger sequencing [2], 
including four-color dye labeling [3-5] and capillary electrophoresis [6], has been the workhorse 
sequencing technology for many years and is still often considered the gold standard. But the 
inherent limitations of Sanger sequencing with regard to throughput have called for the 
development of low-cost and high-throughput “next-generation” DNA sequencing methods [7], 
allowing for more affordable large-scale genome sequencing. Developed high-throughput 
sequencing methods include sequencing by ligation [8, 9] and sequencing by synthesis (SBS).  
Sequencing by synthesis methods, including pyrosequencing [10], Ion Torrent sequencing [11], 
single-molecule-real-time (SMRT) sequencing [12], and SBS using cleavable fluorescent 
reversible terminators [13-15], have led to the achievement of this significant goal. Recently, the 
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use of nanopore-based detection for DNA sequencing with its high-throughput, real-time, and 
single-molecule characteristics has been reported. In addition to the direct strand reading 
nanopore-based approach [16-18], another strategy of using polymer labeled nucleotides (Nano-
SBS) [19-21] with better ability to distinguish the four bases individually has been demonstrated 
by our group.  
 
In this chapter, I review the basics of DNA sequencing, Sanger sequencing, sequencing by 
synthesis (pyrosequencing, SMRT sequencing, SBS using cleavable fluorescent reversible 
terminators, and Nano-SBS), followed by the rationale of this dissertation. 
   
1.1. The Basics of DNA Sequencing 
 
DNA molecules consist of two biopolymer strands forming a double helical structure. Each 
strand of DNA is known as a polynucleotide and is composed of basic building blocks called 
nucleotides. The chemical structure of each nucleotide includes a base, a sugar, and a phosphate 
group. In detail, a polynucleotide is synthesized from a group of monomers, 2’-
deoxyribonucleoside triphosphates (dNTPs), shown in Figure 1-1, where N refers to the base 
(adenine (A), guanine (G), cytosine (C), and thymine (T)). Adenine and guanine are purine 
derivatives; on the other hand, cytosine and thymine are pyrimidine derivatives. In the DNA 
double helix structure, the Watson-Crick base pairing rule, where adenine is always paired with 
thymine and guanine is always paired with cytosine, results in the two DNA strands being 
complementary (see Figure 1-2). Sugar and phosphate groups form the backbone whereas the four 
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alternative bases with a specific sequence order carry the genetic code in the polynucleotide. Due 
to this complementary base-paring, two complementary DNA strands carry the same genetic 
information. In polynucleotide formation, the 5’-alpha-phosphate of the sugar of one dNTP is 
attacked by the 3’-hydroxyl group of the sugar in the adjacent dNTP to form a phosphodiester 
bond, producing a polymer with phosphate groups on the 5’ position of the sugar at one end (5’-
end) and a free hydroxyl group on the 3’ position of the sugar at the other end (3’-end). A DNA 
polymerase catalyzes the reaction. (see Figure 1-3)  
 
Figure 1-1. Chemical structure of 2’-deoxyribonucleoside triphosphate (dNTP). Each nucleotide 






Figure 1-2. A cartoon illustrating two DNA strands in the double helix structure (left), in which 
the bases forming the base pairs are positioned on the inside of the DNA double helical structure, 
whereas the sugar and phosphate groups forming the backbone are positioned on the outside. The 
Watson-Crick base pairs are derived from the specific chemical structures (right), which only 
allow efficient hydrogen bonding between A and T, and between G and C. 
 
 
Figure 1-3. The mechanism of the DNA polymerase reaction. Incorporation of a correct nucleotide 
to the 3’-OH end of a DNA primer strand is an enzymatic biological process, in which the base-
pairing between the incoming nucleotide and the complementary base on the DNA template strand 
guides the extension of the growing strand by addition of this incoming nucleotide. DNA 
polymerase catalyzes the extension reaction by forming a phosphodiester bond and releasing a 
pyrophosphate. In the polymerase reaction, a free hydroxyl group on the 3’-end of the primer 




DNA polymerase (Pol), which executes the consecutive nucleotide additions to the 3’-end of 
an oligonucleotide primer, plays a central role in the reaction. A detailed reaction pathway has 
been proposed for the polymerase reaction [14] and is shown in Figure 1-4. Briefly, in step 1, the 
polymerase (E) binds to the template DNA to form the DNA-polymerase complex; in step 2, an 
incoming nucleotide (dNTP) binds to the complex; step 3 is the noncovalent step preceding 
phosphoryl transfer; step 4 is the phosphoryl transfer; in step 5, the complex’s conformation 
relaxes after the phosphoryl transfer; and in step 6, a pyrophosphate molecule (PPi) is released 
from the complex. In most DNA polymerases, if the correct nucleotide binds to the complex in 
step 2, i.e., one complementary to the next position in the template strand of the DNA-primer 
complex, the reaction will continue through the further steps, the rate-limiting step being the 
noncovalent one preceding phosphoryl transfer (step 3). If an incorrect nucleotide enters the 
complex, the reaction will be unlikely to undergo the further steps, since k4 is greatly reduced. This 
template-guided specificity to select a correct dNTP from structurally similar incorrect molecules 
is referred to as DNA polymerase fidelity. It will be critical to assess this fidelity with the newly 
designed nucleotide analogues to be described in this dissertation. 
 
 
Figure 1-4. The proposed kinetic pathway for the DNA polymerase reaction [14]. The polymerase 
ternary complex converts from the “open” structure to the “closed” structure in step 3, which is 




Based on solved crystal structures of a DNA polymerase ternary complex with DNA template, 
primer, and a nascent ddNTP (Figure 1-5) [22-24], the space around the 3’-position of the 
nucleotide is very limited while the space around the 5’-position and base of the nucleotide is much 
larger. This leads to steric limitations on the use of extensively 3’-O-modified nucleotide 
analogues in the incorporation process. Bulky labeling groups have been attached on the bases [14, 
25, 26] or on the 5’-phosphate [19], leading to successful DNA SBS. More recently, the potential 
of labeling at the 3’-position has been reported [27], although thus far it has only been 
demonstrated for two of the four nucleotides. Detailed molecular designs are reviewed in sections 
1.3 and 1.4. 
 
 
Figure 1-5. The polymerase ternary complex with DNA template, primer and nucleotide. The 
crystal structure of closed conformations [16] (a) shows that the space around the 3’-position is 
limited. The enzymatic active site of the ternary complex with ddCTP [17] (b) shows the 
mechanism of the catalytic reaction with amino acids D190, D192, and D256 coordinating with 




1.2. The Sanger Sequencing Method 
 
In 1977, Frederick Sanger and coworkers [2] reported a DNA sequencing method, introducing 
a chain terminator, 2’, 3’-dideoxyribonucleotide 5’-triphosphate (ddNTP), the so-called chain-
terminator method, to stochastically terminate the growing primers. Because of its ease of 
performance and high reliability, the Sanger sequencing method has been widely used since its 
development. In early Sanger sequencing, the DNA template (sample), primer, DNA polymerase 
and dNTPs were combined in four different reactions with one of the four labeled ddNTPs in each. 
Since these ddNTPs lack a 3’-OH group, forbidding the addition of the following nucleotide, DNA 
elongation ceases when a ddNTP is incorporated. After the incubation, the resulting DNA 
fragments were separated by gel electrophoresis in four individual lanes to obtain the sequencing 
result. Although radioisotopic labeling of the ddNTPs was used in the original method, other 
labeling methods were developed later, including fluorescent labeling [4], as were improved 







Figure 1-6. The principle of Sanger sequencing with four color dye-terminators [38]. A mixture 
of four natural dNTPs and four dye-ddNTPs are combined with DNA polymerase in a single tube. 
The extended products are separated in a single electrophoresis lane and detected by laser-induced 
fluorescence.  
 
1.3. Sequencing by Synthesis (SBS) 
 
The concept of sequencing by synthesis (SBS), which identifies each incorporated nucleotide 
iteratively during the elongation reaction by DNA polymerase, has been a dominant sequencing 
technology in the current generation. The SBS concept was first reported in 1988 by Heyman [39] 
and explosively developed into a variety of approaches, including pyrosequencing, SMRT 
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sequencing, SBS with cleavable fluorescent nucleotide reversible terminators, and Nano-SBS, 
each of which will be reviewed in this section.   
 
1.3.1. Pyrosequencing 
In 1996, Mostafa Ronaghi and coworkers [10, 40] demonstrated pyrosequencing by detecting 
the pyrophosphate released upon the nucleotide incorporation, supporting the concept of 
sequencing by synthesis (SBS), which identifies each incorporated nucleotide iteratively during 
the elongation reaction carried out by DNA polymerase. Pyrosequencing improves the sequencing 
process to a real-time detection. In the pyrosequencing procedure, DNA polymerase, ATP 
sulfurylase, luciferase, apyrase, adenosine 5’ phosphosulfate (APS), and luciferin are added to the 
primer and template; and then, the solutions of nucleotides (dNTPs) are sequentially added and 
removed from the reaction. When the correct complementary nucleotide is added in the reaction, 
it will be incorporated and a pyrophosphate (PPi) will be released. The released PPi reacts with 
APS to form ATP, using ATP sulfurylase as a catalyst. The ATP promotes the conversion of 
luciferin into oxyluciferin. In the last step of this series of reactions, the released PPi is converted 
to a quantifiable detectable light signal. All of the unreacted nucleotides then are degraded by 
apyrase. The principle of pyrosequencing [41] is shown in Figure 1-7. 
 
Although pyrosequencing could read the nucleotide immediately after its incorporation, there 
are several difficulties in this method that limited its application. One difficulty is determining the 
number of nucleotides incorporated in a homopolymeric region.  Theoretically, the intensity of 
emitted light should be proportional to the amount of the released PPi, so that the number of 
10 
 
incorporated nucleotides in a homopolymeric region could be read by the intensity of light detected. 
However, this proportional rule often fails, in practice, if the homopolymeric region is longer than 
4 or 5 bases. That is, if more than four nucleotides have been incorporated in one cycle of reaction, 
the emitted light does not respond as a linear function relative to the number of bases. Another 
limitation is that each of the four nucleotides have to be separately added and detected in each 
sequencing cycle, which decreases the overall efficiency of pyrosequencing. In a related method 
commercialized by Ion Torrent [11], the release of protons in the polymerase reaction are detected 
electronically. 
 




1.3.2. Nucleotide Reversible Terminator (NRT) Pyrosequencing 
In 2007, the Ju group proposed a modified pyrosequencing approach by using reversible 
terminators, so-called NRT pyrosequencing [42], to solve the difficulties of the original 
pyrosequencing. In the original version (section 1.3.1), the major challenge is to determine the 
number of nucleotides incorporated in a homopolymeric region. In NRT pyrosequencing, 
reversible terminators, rather than natural nucleotides, are applied to the sequencing by synthesis 
reaction.  Reversible terminators are nucleotide analogues with a reversibly attached chemical 
moiety, such as 3’-O-(2-nitrobenzyl)-dNTPs [42], 3’-O-allyl-dNTPs [14, 25], 3’-O-azidomethyl-
dNTPs [15, 43], and 3’-O-tert-butyldithiomethyl-dNTPs [44],  capping the 3’-hydroxyl group of 
the four nucleotides (see Figure 1-8(a)). The reversible terminator could be incorporated by DNA 
polymerase to extend the primer by a single nucleotide. However, the reversible terminator does 
not permanently terminate the polymerase chain reaction. After PPi detection, the capping moiety 
on the 3’-hydroxyl group can be efficiency removed for the next extension cycle under mild 
cleavage conditions. Not only does this solve the homopolymeric sequence issue (see Figure 1-8), 
but also, in NRT pyrosequencing four NRTs are simultaneously added in each extension-signal 







Figure 1-8. Comparison of NRT pyrosequencing using 3’-O-modified nucleotide reversible 
terminators (a) with conventional pyrosequencing using natural dNTPs [42]. NRT pyrosequencing 
(b) sequences each base in a homopolymer consecutively, while conventional pyrosequencing (c) 
presents one peak for each homopolymeric region. 
 
1.3.3. SBS with Base-Labeled Cleavable Fluorescent Nucleotide Reversible 
Terminators 
The approach of combining four different color dyes and cleavable 3’-OH blocking groups to 
develop reversibly terminating nucleotides (NRTs) has been developed in our group [13-15, 25]. 
Reversible dye terminators have a removable chemical blocking group at the 3’-hydroxyl position 
and a distinguishing fluorophore linked to each of the four bases through a cleavable linker (Figure 
1-9(a)). Only a single nucleotide analogue complementary to the nucleotide in the next position in 
the template is incorporated by DNA polymerase. As a reversible terminator, it temporarily 
terminates the polymerase reaction since a small chemical blocking group at the 3’-hydroxyl 
position prevents the incoming nucleotide from connecting to the 3’-end of the primer. The 
incorporated nucleotide is identified by detecting its unique fluorescence emission signature, and 




Figure 1-9. The molecular designs of two versions of the fluorescent SBS method are represented 
by a reversible dye-terminator (a) as well as a combination of four nucleotide reversible 
terminators and four cleavable fluorescent dideoxynucleotides (b). The chemical structures of 
nucleotide reversible terminators (NRTs) with different 3’-O blocking moieties (allyl, azidomethyl, 
tert-butyldithiomethyl, or 2-nitrobenzyl groups) are shown at right. In general, the NRTs with 
larger 3’-O-blocking moieties, such as 2-nitrobenzyl group, are not efficiently incorporated by 
polymerase in comparison with the NRTs with smaller 3’-O-blocking groups, such as allyl group. 
 
reaction to permit the next cycle of SBS. Although this sequencing approach possesses the 
advantages of the reversible terminator and the four-color dye-labeling concept, degradation of the 
signal-to-noise ratio with increasing cycles of nucleotide addition has been noted. To improve the 
read length, a later version of the SBS approach was developed using a combination of four 
reversible terminators and four cleavable fluorescent dideoxynucleotides [15] (Figure 1-9(b)). The 
concept of this design is that, due to a competition between these two types of added nucleotides 
in the polymerase reaction when they are added in an appropriate ratio, enough non-reversibly 
terminating fluorescent dideoxynucleotides should be incorporated to give sufficient fluorescence 
for base calling, with the remaining non-fluorescent reversible terminators extending the reaction 
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to the next position with high efficiency and without leaving a chemical scar on the base. Although 
each approach has been reported with specific removable chemical moieties (reviewed next), each 
removable chemical moiety could be replaced by several others.   
 
Four-color SBS with allyl-based cleavable fluorescently modified reversible terminators 
In 2006, the allyl-based cleavable fluorescently modified nucleotide analogues were reported 
by our group as a tool set for conducting four-color SBS [14]. Briefly, the design and synthesis of 
4 different fluorescent dye-labeled reversible terminators (3’-O-allyl-dCTP-allyl-Bodipy-FL-510, 
3’-O-allyl-dUTP-allyl-R6G, 3’-O-allyl-dATP-allyl-ROX, and 3’-O-allyl-dGTP-allyl-Bodipy-650) 
as well as their performance sequencing a chip-immobilized self-priming DNA template have been 
described. High accuracy sequencing was achieved:  showing at least 13 nucleotides were correctly 
called in non-homopolymeric sequences and 20 nucleotide sequences were obtained for a template 
with two homopolymeric regions. The cleavable fluorescent nucleotide reversible terminators 
consist of a distinct fluorescent dye attached to the 5-position of pyrimidines (C and T) and the 7-
position of purines (A and G) via an allyl-based cleavable linker; and a 3’-O-allyl chemical moiety 
capping the 3’-OH group. The chemical structures of these nucleotide analogues are shown in 
Figure 1-10. In the incorporation reaction, these allyl-based cleavable fluorescently modified 
reversible terminators could be recognized by a DNA polymerase with high fidelity and high 
efficiency. After deallylation, the fluorophore and the 3’-O-allyl group on the DNA extension 
products are removed simultaneously, resulting in only a small fragment of the linker moiety (i.e., 




Four-color SBS with azido-based cleavable fluorescently modified terminators 
In 2008, a hybrid SBS procedure to improve the read length using 3’-O-modified nucleotide 
reversible terminators (NRTs) and cleavable fluorescent dideoxynucleotide (ddNTPs) was 
reported by our group [15]. The design and synthesis of four 3’-O-azidomethyl dNTPs (3’-O-N3-
dATP, 3’-O-N3-dCTP, 3’-O-N3-dGTP, and 3’-O-N3-dTTP) and four ddNTP-azidolinker-
fluorophores (ddCTP-N3-Bodipy-FL-510, ddUTP-N3-R6G, ddATP-N3-ROX, and ddGTP-N3-
Cy5), whose molecular chemical structures are shown in Figure 1-11, as well as their combined 
use to perform SBS was demonstrated, resulting in a longer read length (32 bases) and high 
accuracy sequencing. A unique fluorescent dye was attached to the 5-position of pyrimidines (C 
and T) and the 7-position of purines (A and G) via an azido-based cleavable linker. In the 
incorporation step all 8 nucleotide analogues were added simultaneously. A competition between 
a 3’-O-azidomethyl dNTP and a ddNTP-azido linker-fluorophore in the polymerase reaction 
resulted in a small portion of extended products with fluorescently-labeled terminators, which 
could be detected with sufficient sensitivity, and a major portion of products extended by the 
nucleotide reversible terminator, which keeps all the products aligned for the subsequent cycle. 
After chemical cleavage of the azidomethyl moiety, a modified propargylamino moiety remains 
on a DNA extension product extended by a terminator but these are not extended further; and the 
3’-OH group is regenerated at the end of a DNA extension product extended by a reversible 




Figure 1-10. Chemical structures of 3’-O-allyl-dNTP-allyl linker-fluorophores (3’-O-allyl-dCTP-






Figure 1-11. Chemical structures of ddNTP-azido linker-fluorophores (ddCTP-N3-BodipyFL-510, 








In 2012, the strategy of tagged nucleotide Nano-SBS, a single molecule electronic sequencing 
by synthesis approach with nanopore detection was first demonstrated by our group [19], 
accurately distinguishing four bases by detecting four different sized poly(ethylene glycol) (PEG) 
tags released from 5’-phosphate-modified nucleotides passing through the -HL nanopore. As 
each 5’-phosphate-tag nucleotide is incorporated into the growing primer strand during the 
polymerase reaction, its tag is released by phosphodiester bond formation. The tags will enter the 
nanopore in the order of their release, generating unique ionic current blockade signatures due to 
their distinct chemical structures. In 2016, further development of this approach was reported using 
oligonucleotide-based polymer tags [20, 21]. While an incoming complementary tagged 
nucleotide forms a ternary complex with primer, template, and polymerase, its tag enters the 
nanopore to generate its unique current blockade level. Four nucleotides are tagged with four 
different polymers, which are detected as four distinguishable and sequence-specific current 
signatures.  The approach was able to sequence one base at a time in real time and the signal 
detection time was relatively easy to control. This approach coupled with polymerase attached to 
the nanopores in an array format should yield a high-throughput single-molecule real-time 




Figure 1-12. Nano-SBS relies on a nanopore-polymerase sequencing engine (a) in which a single 
DNA polymerase molecule covalently attached to an αHL nanopore heptamer, binding with primer 
and template DNA (shown as a double-hairpin conformation) and the incoming tagged nucleotide 
form a ternary complex with the polymerase. SBS schematic (b) showing the sequential capture 
and detection of tagged nucleotides (c) by the nanopore as they are incorporated into the growing 
DNA strand in the polymerase reaction to produce nucleotide-specific current blockades [20]. (C3 
= propanol; dSp = abasic spacers; FldT = fluorescein-dT)  
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1.4. Overview and Rationale for the design and synthesis of novel nucleotide analogues 
for SBS in this Dissertation  
 
The previously proposed molecular structures of nucleotide analogues for SBS using cleavable 
fluorescent reversible terminators shares a general molecular formula. A unique fluorescent dye is 
linked to the 5-position of the pyrimidines (T and C) and the 7-position of purines (G and A) via 
a cleavable linker, and a small chemical moiety is used to cap the 3′-OH group; the resulting 
nucleotide analogues should incorporate into the growing DNA strand as terminators. The detailed 
molecular structures have been reviewed in section 1.3. In this approach, the nucleotides are 
modified at two specific locations in such a way that they still can be recognized by DNA 
polymerase as substrates: (1) a different fluorophore with a distinct fluorescent emission is 
attached to the specific location of each of the four bases through a cleavable linker and (2) the 3′-
OH group is capped by a small chemically reversible moiety. DNA polymerase only incorporates 
a single nucleotide analogue complementary to the base on a DNA template. After incorporation, 
the unique fluorescence emission is detected to identify the incorporated nucleotide. The 
fluorophore is subsequently removed and the 3′-OH group is chemically regenerated, which allows 
the next cycle of the polymerase reaction to occur.  
 
One complication of the above mentioned molecular design of nucleotide analogues for the 
SBS approach is the production of a small molecular “scar” (a propargylamine or a modified 
propargylamino moiety) (see Figure 1-13) on the nucleotide base after cleavage of the fluorescent 
dye from the incorporated nucleotide in the polymerase reaction. This might result in the limitation 
of read length in DNA sequencing due to the accumulation of scars on the growing DNA strand. 
As the sequencing proceeds, the accumulation of these residual scars may be significant enough 
to interfere with the DNA double helix structure, thereby negatively affecting DNA polymerase 
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recognition and consequently limiting the read length.  To surmount this obstacle to achieving long 
sequence reads, it is desirable to explore DNA SBS schemes in which the florescent dye (reporter) 
is attached directly to the 3’-OH group of the nucleotide analogues via a cleavable linker that will 
result in scarless SBS. The goal of this scarless SBS is to generate naturally elongated DNA during 
the DNA synthesis after each cycle of sequencing and to generate a natural DNA double helical 
structure at the end of the SBS process.  
 
 
Figure 1-13. The “scar” moiety remaining on the base after chemically removing the florescent 
dye and regeneration of the 3’-OH group of the DNA extension products when either an allyl linker 
[14, 25] (a) or an azido-linker [15, 43] (b) are attached to the base. 
 
 
The major challenge for the design of such 3’-O-modified nucleotide analogues is that they 
must be accepted by DNA polymerase as substrates. In 1994, Canard et.al. [45] reported 3’-O-
fluorescently modified nucleotides with an ester linkage. By performing enzymatic reactions with 
a modified T7 DNA polymerase, 3’-O-ester linker-fluorescein-dTTP (see Figure 1-14(a)) could 
be recognized and incorporated at the 3’ end of the primer; however, 3’-O-ester linker-N-
methylanthranilate-dCTP (see Figure 1-14(b)) could not be recognized. The cleavage of the 3’-
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ester linkage was also demonstrated by chemical and enzymatic methods. In 1999, Weich et.al. 
[46] attempted to develop a 3’-O-photocleavable linker-fluorescently modified nucleotide 
reversible terminator, based on the earlier synthesis of the photocleavable nucleotide reversible 
terminator 3’-O-(2-nitrobenzyl)-dATP [43]. Although the designed nucleotides, with the 
fluorescently modified 2-nitrobenzyl moiety either directly attached at the 3’-O position (see 
Figure 1-14(c)) or attached via a carbonate linker (see Figure 1-14(d)), have been successfully 
synthesized, they could not be recognized by several tested DNA polymerases (including Klenow, 
rTth DNA polymerase, Vent (exo-) DNA polymerase, Ampli Taq DNA polymerase, and Ampli 
Taq FS). Recently, Kim et.al. [27, 47] reported 3’-O-fluorescently modified nucleotides using an 
allyl linker to attach the fluorescent dye and showed that a 3’-O-reversible dNTP with small dyes 
(coumarin, Pacific Blue and BodipyFL) attached at the 3’-O-allyl linker are reasonably good 
substrates for TherminatorTM II DNA polymerase. However, bulky dyes (such as Atto dyes) or 
highly charged dyes (such as Alexa 488), attached to the same linker are not substrates for DNA 
polymerase. In Kim’s work, 3’-O-allyl linker-BodipyFL-dTTP (see Figure 1-14(e)) and 3’-O-allyl 
linker-Pacific Blue-dATP (see Figure 1-14(f)) were chosen to demonstrate SBS. Accumulated 
research efforts indicate that the major challenge for this approach is that the DNA polymerase has 
difficulty accepting the 3’-O bulky-dye-modified nucleotide as a substrate because the 3′ position 
on the deoxyribose of the complementary nucleotide is very close to the amino acid residues in the 
active site of the DNA polymerase in the ternary complex formed by the polymerase with the 




Figure 1-14. Summary of chemical structures of 3’-O-reversible linker-fluorescently modified 
nucleotide reversible terminators. Analogues of (a), (e), and (f) could be incorporated, however 
analogues of (b), (c), and (d) could not be incorporated by DNA polymerases tested.  
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The above literature survey indicates that only a few 3’-O-cleavable fluorescently modified 
nucleotides could be recognized by an engineered DNA polymerase. An alternative 3’-O-reversble 
nucleotide analogue has been proposed in this study. The rationale behind this novel nucleotide 
analogue is the use of a dual-function linker attached at the 3’-OH position with a small enough 
size to fit into the active site and permit its incorporation by DNA polymerase. This dual function 
linker must not only connect with the reporter molecule after the nucleotide is incorporated (the 
labeling step in the sequencing process) but must be able to regenerate the 3’-OH after the linker 
is chemically removed (the regeneration step). For its labeling function, the linker should have an 
exclusive functional group which can only react with a complementary functional group on the 
reporter molecule, but neither group should react with DNA polymerase, DNA (template, primer) 
or other nucleotides. Furthermore, the reaction should have a high efficiency at low concentration. 
The labeling reaction should perform well in the aqueous conditions at which the sequencing 
process is carried out. For its regeneration function, the linker could include one of the existing 
chemical moieties previously described on reversible terminators (e.g., allyl, 2-nitrobenzyl, 
azidomethyl, or dithiomethyl groups). 
 
In this study, we construct nucleotide analogues using 3’-O-dithiomethyl (3’-O-DTM; 3’-O-
SS) as the linker to directly or indirectly attach a fluorescent reporter as novel scarless nucleotide 
reversible terminators for DNA SBS. In this set of novel NRTs, the 3’-OH is reversibly blocked 
with the dithiomethyl group [44] that is in turn labeled with a fluorescent dye or with an anchor 
for subsequent attachment of a fluorescent dye, thereby serving as both the reversible blocker and 
the cleavable fluorescent reporter of the 3’-O-modified nucleotide analogue. Our novel SBS design 
relies on the incorporation of 3’-O-SS-cleavable anchor nucleotide analogues, a subsequent 
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labeling reaction with a fluorescently tagged anchor binding molecule for imaging, and then 
cleavage (see Figure 1-15). Since attaching smaller groups to the 3’-O position of the nucleotide 
analogue does not substantially interfere with the ability of DNA polymerase to recognize these 
molecules as substrates, these NRTs are efficiently incorporated into the growing DNA strand 
during SBS. After nucleotide incorporation, a corresponding labeled binding molecule tethered 
with a fluorescent dye will react with the anchor at the 3’-O end of the DNA extension product. 
Imaging of the fluorescent dye on this DNA extension product will identify the incorporated 
nucleotide for sequence determination. After nucleotide incorporation and imaging, the 3’-O-SS-
dye will be cleaved using tris(3-hydroxypropyl) phosphine (THP) to generate a 3’-OH group (see 
Figure 1-16) that is ready for subsequent extension reactions. 
 
The anchor moieties include a variety of orthogonally reactive or affinitive functionalities with 
high efficiency and specificity, such as biotin [26] and trans-cyclooctene (TCO) [48, 49], which 
will efficiently bind or react with streptavidin and tetrazine (TZ), respectively. The DNA 
polymerase will readily incorporate these 3’-O-anchor-modified nucleotides to the growing DNA 
strand to terminate DNA synthesis. Addition of the labeled binding molecules (such as different 
dye-labeled streptavidin and TZ molecules) to the corresponding primer extension product leads 
to binding of the labeled binding molecules to the corresponding "anchor" moiety at the 3’ end of 
the primer extension product (Figure 1-17 and Figure 1-18); after washing away unbound labeled 
molecules, the detection of the unique label attached to the 3’ end of the primer extension product 





Figure 1-15. Scarless SBS using 3'-O-"Anchor"-SS-dNTPs and corresponding labeled binding 
molecules. (STEP 1) Addition of a DNA polymerase to the primed template moiety (only the 
primer strand is shown above) leads to the incorporation of a complementary 3'-O-"Anchor"-SS-
dNTP to the 3' end of a primer with high efficiency and specificity. (STEP 2) Addition of labeled 
binding molecules to the corresponding primer extension products leads to orthogonal binding of 
the labeled binding molecules to the corresponding "anchor" moiety at the 3’ end of the primer 
extension product; after washing away the unbound labeled molecules, the detection of the unique 
label attached to the 3’ end of the primer extension product determines the identity of the 
incorporated nucleotide. (STEP 3) Addition of THP results in the cleavage of the disulfide bond, 
and therefore to the removal of the label on the primer extension product and the regeneration of 
the 3'-OH on the primer extension product. The repetition of STEP 1 through STEP 3 allows for 






Figure 1-16. The mechanism of THP cleavage of the dithiomethyl linker. 
 
 
Figure 1-17. Conjugation of a dye-labeled streptavidin to the 3’ end biotin of an extension primer 





Figure 1-18. Conjugation of a dye-labeled tetrazine to the 3’ end TCO of an extension primer to 
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Chapter 2 Design and Synthesis of 3’-O-SS-Cleavable Fluorescent/Anchor 
Modified Nucleotide Reversible Terminators for 4-Color SBS 
 
2.1. Introduction  
 
To develop the set of 3’ reversibly fluorescent labeled nucleotides for scarless SBS, nucleotide 
analogues with directly attached fluorescent dyes (3’-O-SS-clevable fluorescent nucleotide 
analogues) for two of the four bases (i.e., A and T) and nucleotide analogues with directly attached 
anchors (3’-O-SS-cleavable anchor nucleotide analogues) for the other two of the four bases (i.e. 
C and G) have been constructed, along with dye-labeled anchor binding molecules. For 
demonstration of the 4-color SBS approach, 3’-O-fluorescent/anchor-SS-dNTPs (3’-O-ROX-SS-
dATP, 3’-O-BodipyFL-SS-dTTP, 3’-O-Biotin-SS-dCTP and 3’-O-TCO-SS-dGTP; see Figure 2-
1) have been designed and synthesized. Furthermore, to take advantage of their potentially higher 
incorporation efficiency (see section 3.2), 3’-O-SS-cleavable fluorescent/anchor nucleotide 
analogues with a PEG-elongated linker (3’-O-ROX-PEG4-SS-dATP, 3’-O-BodipyFL-PEG4-SS-
dTTP, 3’-O-Biotin-PEG4-SS-dCTP and 3’-O-TCO-PEG4-SS-dGTP; see Figure 2-2) have been 
synthesized, and tested for incorporation and cleavage, as described in this chapter. 
 
To design 3’-O-SS-cleavable modified nucleotides, a cleavable dithiomethyl moiety [1] was 
directly attached to the 3’-O position of the nucleotides to form precursor nucleotides (Figure 2-
3), followed by attachment of an anchor moiety (or a fluorescent dye) at the end of the linker. The 
cleavable moiety joins to the 3’-O position of the nucleotides, allowing the whole linker to be 
removed and the 3’-OH to be regenerated at the same time. One advantage of the precursor 
nucleotides is that they provide flexibility in SBS procedure design, allowing attachment of a 
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variety of reporter moieties (fluorescent dyes) or anchors (for subsequent labeling with fluorescent 
dyes) at the last step of synthesis.  An amine group at the far end of the linker of the precursor 
nucleotide permits coupling with NHS ester derivatives of an anchor or a fluorescent dye via an 
amide bond.  
 
 
Figure 2-1. Chemical structures of 3’-O-Fluorescent/Anchor-SS-dNTPs (with a short linker) (3’-




Figure 2-2. Chemical structures of 3’-O-Fluorescent/Anchor-PEG4-SS-dNTPs (with a PEG linker) 







Figure 2-3. Synthesis of the 3’-O-SS-cleavable fluorescent/anchor nucleotide reversible 
terminators. The anchor (or fluorescent dye) was attached to the 3’-O position of nucleotides by 
coupling its NHS ester derivative to the amino group at the end of the cleavable linker of the 
nucleotide precursor. R could be an anchor or a fluorescent dye. 
 
In the reaction to attach the sulfide derivative to the 3’-O of the nucleoside, the direct 
attachment of a methylthiomethyl (MTM) group to alcohols to form MTM ethers has been reported 
by Medina et. al. [2], following the mechanism for the modified Pummerer rearrangement (see 
Figure 2-4).  
 




To synthesize nucleoside triphosphates from nucleoside analogues, another highly 5’-selective 
phosphorylation of the nucleoside has been developed involving the reagent 2-chloro-4-H-1,3,2-
benzodioxaphosphorin-4-one (salicyl phosphorochoridite). Two reaction pathways of this type of 
phosphorylation have been reported depending on the synthetic procedure (see Figure 2-5). 
Ludwig and co-workers [3, 4] reported that the 5’-hydroxyl group of the nucleoside is activated 
by salicyl phosphorochoridite, followed by addition of tributylammonium pyrophosphate to 
produce a nucleoside 5’-cyclic triphosphite intermediate. Caton-Williams and co-workers [5, 6] 
reported an alternative approach in which the reaction of salicyl phosphorochoridite and 
tributylammonium pyrophosphate generates a phosphitylating reagent in situ, followed by addition 
of nucleoside to produce a nucleoside 5’-cyclic triphosphite intermediate. After oxidization of the 
nucleoside 5’-cyclic triphosphite intermediate with iodine, a nucleoside 5’-cyclotriphosphate 
intermediate is formed. Subsequently, this intermediate is hydrolyzed to afford the nucleoside 5’-
triphosphate. In the Caton-Williams approach, a high yield of nucleoside 5’-triphosphates is 
obtained from the non-protected nucleosides, while in the Ludwig approach, protection of the 3’ 
(or 2’)-hydroxyl group is needed to afford a high yield of nucleoside 5’-triphosphates. I prepared 




Figure 2-5. The detailed synthetic pathway for preparation of 2’-deoxynucleoside 5’-triphosphates 
from 2’-deoxynucleosides, involving the reagent 2-chloro-4-H-1,3,2-benzodioxaphosphorin-4-
one in the triphosphorylation reaction. R indicates H or capping groups. 
 
2.2. Design and Synthesis of 3’-O-SS-Cleavable Fluorescent/Anchor Modified NRTs  
2.2.1. Synthesis of 3’-O-BodipyFL-SS-dTTP and 3’-O-BodipyFL-PEG4-SS-dTTP 
 
The 3’-O-reversible fluorescent modified nucleotides, 3’-O-BodipyFL-SS-dTTP (6) and 3’-O-
BodipyFL-PEG4-SS-dTTP (7), have been designed to be potential NRTs for SBS. The synthetic 
procedures for each intermediate, which follow or are modified from synthetic approaches in the 
literature, are provided as Scheme 2-1. First, thiodimethylethylamine was protected with a 
trifluoroacetic group to form 2,2,2-trifluoro-N-(2-mercapto-2-methylpropyl)acetamide (1). Then, 
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the 5’-O-tert-butyldimethylsilyl thymidine was reacted with DMSO, acetic acid and acetic 
anhydride to form 3’-O-methylthiomethyl-5’-O-tert-butyldimethylsilyl thymine (2) [2], which 
further reacted with sulfuryl chloride, potassium p-toluenethiosulfonate, and the prepared thio 
compound (1) in order to form 3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl) disulfanylmethyl)-
5'-O-tert-butyldimethylsilyl thymidine (3). After the tert-butyldimethylsilyl protecting group was 
removed with 1.0M TBAF in THF to regenerate the 5’ hydroxyl group [7], 3’-O-((1,1-dimethyl-
2-trifluoroacetamidoethyl)disulfanylmethyl) thymidine (4) was formed. The thymidine derivative 
reacted with 2-chloro-4-H-1,3,2-benzodioxaphosphorin-4-one and tributylammonium 
pyrophosphate, following by oxidation and treatment with ammonium hydroxide to produce 3’-
O-NH2-SS-dTTP (5) [5, 6] which has been characterized by high resolution mass spectrometry 
(HRMS). To synthesize the fluorescent modified nucleotide, the BodipyFL-NHS ester was 
conjugated to the linker to form the final compound 3’-O-BodipyFL-SS-dTTP (6), which has been 
characterized by HRMS. For the PEG4 elongated linker, the BodipyFL-PEG4-NHS ester was 
conjugated to the linker to form the final compound 3’-O-BodipyFL-PEG4-SS-dTTP (7), which 




Scheme 2-1. Synthesis of 3’-O-BodipyFL-SS-dTTP (6) and 3’-O-BodipyFL-PEG4-SS-dTTP (7). 
 
2,2,2-trifluoro-N-(2-mercapto-2-methylpropyl)acetamide (1) 
2-amino-1,1-dimethylethylthiol hydrochloride (7.08 g, 50 mmol) was dissolved in 30 mL 
anhydrous pyridine and 60 mL anhydrous benzene, stirring under argon at 0 oC for 30 minutes. 
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Then, 14 mL (100 mmol) trifluoroacetic anhydride was added dropwise to the reaction mixture, 
stirring under argon at r.t. overnight. After the reaction was complete, the volume of solvent was 
reduced under vacuum and extracted twice with 100 mL DCM. The organic layers were combined, 
washed with 0.5 M HCl (aq), and dried over anhydrous sodium sulfate (Na2SO4). Concentration 
and purification by flash column chromatography on silica gel (ethyl acetate:hexane = 3:7) gave 
9.0 g  2,2,2-trifluoro-N-(2-mercapto-2-methylpropyl)acetamide (1) (90%). 1Η ΝΜR (400 MHz, 
DMSO-d6):  1.28 (s, 6H), 2.89 (s, 1H), 3.34 (m, 2H), 9.49 (s, 1H); 13C ΝΜR (100 MHz, DMSO-
d6):  30.16, 44.88, 52.20, 116.53 (q, J = 286 Hz), 157.34 (q, J = 36 Hz); 19F ΝΜR (376 MHz, 
DMSO-d6): -73.08.  
 
3’-O-methylthiomethyl-5'-O-tert-butyldimethylsilyl thymidine (2) 
5'-O-tert-Butyldimethylsilyl thymidine (1.07 g, 3 mmol) was dissolved in 10 mL anhydrous 
DMSO, followed by addition of 2.6 mL acetic acid, stirring at r.t. for 30 minutes. Then, 8.6 mL 
acetic anhydride was added dropwise to the reaction, stirring at r.t. for 48 hours. After the reaction 
was complete (as monitored by TLC), the reaction was quenched by slowly adding saturated 
NaHCO3 aqueous solution with vigorous stirring and extracted three times with 30 mL of ethyl 
acetate. The combined organic layers were dried over anhydrous sodium sulfate (Na2SO4). After 
removing the solvent, the residue was purified by flash column chromatography on silica gel (ethyl 
acetate:hexane = 1:2) to give 0.92 g pure compound (2) (74%). 1H NMR (400 MHz, DMSO-d6): 
δ 0.099 (s, 6H), 0.90 (s, 9H), 1.79 (s, 3H), 2,103 (s, 3H), 2.120 - 2.176 (m, 1H), 2.24 – 2.28 (m, 
1H), 3.76-3.78 (m, 2H), 3.98-3.98 (m, 1H), 4.39 - 4.41 (m, 1H), 4.72 (s, 2H), 6.11-6.14 (m, 1H), 
7.49 (s, 1H), 11.35(s, 1H); 13C NMR (100 MHz, DMSO-d6 ): -5.03, -5.00, 12.67, 13.72, 18.42, 
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26.23, 36.48, 63.61, 73.03, 76.47, 84.45, 84.51, 110.06, 135.84, 150.83, 164.10; HRMS (ESI+) 
m/z calculated for C18H33N2O5SSi [(M+H)+]: 417.1879, found: 417.1890. 
 
3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl)-5'-O-tert-butyl 
dimethylsilyl thymidine (3) 
3’-O-methylthiomethyl-5'-O-tert-butyldimethylsilyl thymidine (2) (625 mg, 1.50 mmol) was 
dissolved in 20 mL anhydrous dichloromethane, followed by addition of 0.3 mL cyclohexene and 
2g molecular sieves (3 Å), stirring under argon at r.t. for 30 minutes. The mixture was cooled in 
an ice-water bath and then fleshly distilled solution of sulfuryl chloride (0.12 mL, 1.50 mmol) in 
3 mL of anhydrous dichloromethane was added dropwise over 2 minutes. The ice-water bath was 
removed and the reaction mixture was stirred for a further 30 minutes. The solvent was removed 
under reduced pressure, and then dried under high vacuum for 10 minutes. The mixture was 
redissolved in 10 mL anhydrous DMF, followed by addition of 0.61 g potassium p-
toluenethiosulfonate in 3.0 mL anhydrous DMF, stirring at r.t. for 1 hour. A solution of 403 mg 
2,2,2-trifluoro-N-(2-mercapto-2-methylpropyl)acetamide (1) was added to the reaction mixture, 
stirring under argon at r.t. for 3 hours. After the reaction was complete, the reaction was quenched 
by slowly addiing 30 mL water and extracted three times with 30 mL ethyl acetate. The combined 
organic layers were dried over anhydrous sodium sulfate (Na2SO4). After removing the solvent, 
the residue was purified by flash column chromatography on silica gel (ethyl acetate:hexane = 1:2) 
to give 450 mg pure 3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl) disulfanylmethyl)-5'-O-tert-
butyldimethylsilyl thymidine (3) (50%).  1H NMR (400 MHz, DMSO-d6): δ 0.10 (s, 6H), 0.90 (s, 
9H), 1.24 (s, 6H), 1.79 (s, 3H), 2.12 - 2.19 (m, 1H), 2.29 – 2.34 (m, 1H), 3.36-3.38 (m, 2H), 3.74-
3.82 (m, 2H), 4.02-4.03 (m, 1H), 4.39 - 4.40 (m, 1H), 4.93 (s, 2H), 6.10-6.14 (m, 1H), 7.49 (s, 1H), 
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9.48 (t, J = 6 Hz, 1H), 11.353(s, 1H); 13C NMR (100 MHz, DMSO-d6): -5.02, -4.99, 12.67, 18.44,  
25.61, 26.25, 36.59, 48.35, 50.70, 63.63, 78.15, 80.08, 84.31, 84.39, 110.06, 116.48 (q, J = 286 
Hz), 135.78, 150.81, 157.34 (q, J = 36 Hz), 164.08; 19F NMR (376 MHz, DMSO-d6 ): -73.06; 
HRMS (ESI+) m/z calculated for C23H38F3N3O6S2Si [(M+H)+]: 602.2002, found: 602.1998. 
 
3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl) thymidine (4) 
3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl)-5'-O-tert-butyldimethylsilyl 
thymidine (3) (250 mg, 0.42 mmol) was dissolved in 10 mL THF, followed by addition of a 1.0 
mL solution of 1.0 M TBAF in THF. After reaction was complete (as monitored by TLC), the 
solvent was reduced in vacuo, followed by addition of 50 mL saturated NaHCO3 aqueous solution. 
The mixture was extracted with 100 mL dichloromethane twice. The organic layers were dried 
over anhydrous sodium sulfate (Na2SO4). After removing the solvent, the residue was purified by 
flash column chromatography on silica gel (DCM:methanol = 20:1) to give 199 mg 3’-O-((1,1-
dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl) thymidine (4) (97%). 1H NMR (400 MHz, 
DMSO-d6): δ 1.25 (s, 6H), 1.79 (s, 3H), 2.15 - 2.22 (m, 1H), 2.26 – 2.30 (m, 1H), 3.37-3.38 (m, 
2H), 3.60 (s, 2H), 3.97 (m, 1H), 4.40 (m, 1H), 4.88-4.91 (s, 2H), 5.15 (t, J = 1.3Hz, 1H), 6.12 (t, J 
= 6.4 Hz, 1H), 7.71 (s, 1H), 9.48 (t, J = 6.0 Hz, 1H), 11.31 (s, 1H); 13C NMR (100 MHz, DMSO-
d6 ): 12.72, 25.64, 36.61, 48.37, 50.69, 61.81, 78.50, 80.08, 84.26, 84.84, 110.03, 116.49 (q, J = 
286 Hz), 136.38, 150.90, 157.34 (q, J = 36 Hz), 164.14; 19F NMR (376 MHz, DMSO-d6 ): -





3’-O-((2-amido-1,1-dimethylethyl)disulfanylmethyl)-dTTP; 3’-O-NH2-SS-dTTP (5)  
3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl) thymidine (4) (50 mg, 103 
μmol), tributylammonium pyrophosphate (150 mg, 0.27mmol) and 2-chloro-4-H-1,3,2-
benzodioxaphosphorin-4-one (33 mg, 0.17 mmol) were dried separately under high vacuum over 
P2O5 overnight at ambient temperature. The tributylammonium pyrophosphate was dissolved in 1 
mL anhydrous DMF under argon, followed by addition of 1.5 mL tributylamine. The mixture was 
added into a solution of 2-chloro-4-H-1,3,2-benzodioxaphosphorin-4-one in 2 mL anhydrous DMF, 
stirring under argon at r.t. for 1 hour. Then, the reaction mixture was added to the solution of 
compound (4) in 2 mL anhydrous DMF, stirring at r.t. for another 1 hour. Iodine solution (0.02 M 
iodine/ pyridine/ water) was then injected into the reaction mixture, stirring for 10 minutes, until a 
permanent brown color was observed. 30 mL water was added to the reaction mixture, stirring at 
r.t. for an additional 2 hours.  Then, 30 mL ammonium hydroxide (NH4OH) was added and the 
reaction was stirred at r.t. overnight. After volatiles were reduced under vacuum, the reaction 
mixture was extracted with 50 mL ethyl acetate. The aqueous layer was collected, followed by 
lyophilization to remove water, leaving a white solid. The solid was eluted by fresh ion-exchange 
chromatography on a DEAE-Sephadex A-25 column at 4°C with TEAB buffer in a concentration 
gradient from 0.1 M to 1.0 M. The crude product was further purified by reverse phase HPLC to 
give 3’-O-NH2-SS-dTTP (5), which was characterized by HRMS (ESI-) m/z calculated for 
C15H28N3O14P3S2 [(M-H)-]: 630.0147, found 630.0142. 
 
3’-O-BodipyFL-SS-dTTP (6) 
3’-O-NH2-SS-dTTP (5) (2.5 mg, 4.0μmol) was dissolved in 0.3 mL 0.1 M NaHCO3/Na2CO3 buffer 
(pH 8.9), followed by addition of a solution of 1.5 mg BodipyFL-NHS ester in 0.2 mL anhydrous 
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DMF, stirring at r.t. for 3 hours with exclusion of light. The crude product was then purified by 
ion-exchange chromatography on a DEAE-Sephadex A-25 column at 4°C with TEAB buffer in a 
concentration gradient from 0.1 M to 1.0 M, and further purified by reverse phase HPLC to afford 
3’-O-BodipyFL-SS-dTTP (6), which was characterized by HRMS (ESI-); m/z calculated for 
C29H41BF2N5O15P3S2 [(M+2Na-3H)-]: 948.0881, found: 948.0846. 
 
3’-O-BodipyFL-PEG4-SS-dTTP (7) 
BodipyFL-PEG4-Acid (2.1 mg, 3.8 μmol) was dissolved in 0.2 mL anhydrous DMF, followed by 
addition of 1.03 mg of N,N-disuccinimidyl carbonate and 0.48 mg 4-dimethylaminopyridine, 
stirring at r.t. for 2 hours.  After complete conversion to compound BodipyFL-PEG4-NHS ester 
(as monitored by TLC), the mixture was directly used to couple with a solution of 3’-O-NH2-SS-
dTTP (5) (2.4 mg, 3.8 μmol) in 0.3 mL 0.1 M NaHCO3/Na2CO3 buffer (pH 8.8), stirring at r.t. for 
3 hours with exclusion of light. The crude product was then purified by fresh ion-exchange 
chromatography on a DEAE-Sephadex A-25 column at 4°C with TEAB buffer in a concentration 
gradient from 0.1 M to 1.0 M, and further purified by reverse phase HPLC to afford 3’-O-
BodipyFL-PEG4-SS-dTTP (7), which was characterized by HRMS (ESI-); m/z calculated for 








2.2.2. Synthesis of 3’-O-ROX-SS-dATP and 3’-O-ROX-PEG4-SS-dATP 
 
The 3’-O-reversible fluorescent modified nucleotides, 3’-O-SS-ROX-dATP (12) and 3’-O-
ROX-PEG4-SS-dATP (13), have been designed to be potential NRTs for SBS. The synthetic 
procedures for each intermediate, which follow or are modified from synthetic approaches in the 
literature, are provided as Scheme 3-2. First, the N4-benzoyl-5'-O-tert-butyldimethylsilyl-2'-
deoxyadenosine was reacted with DMSO, acetic acid and acetic anhydride to form the N4-benzoyl-
3’-O-methylthiomethyl-5'-O-tert-butyldimethylsilyl-2'-deoxyadenosine (8) [2], which further 
reacted with sulfuryl chloride, potassium p-toluenethiosulfonate, and the prepared thio compound 
(1) in order to form N4-benzoyl-3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl) disulfanylmethyl) 
-5'-O-tert-butyldimethylsilyl-2'-deoxyadenosine (9). After the tert-butyldimethylsilyl protecting 
group was removed with 1.0M of TBAF in THF to regenerate the 5’ hydroxyl group [7], N4-
benzoyl-3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl) disulfanylmethyl)-2'-deoxyadenosine 
(10) was formed. The thymidine derivative reacted with 2-chloro-4-H-1,3,2-
benzodioxaphosphorin-4-one and tributylammonium pyrophosphate, following by oxidation and 
treatment with ammonium hydroxide to produce 3’-O-((2-amino-1,1-
dimethylethyl)disulfanylmethyl)-dATP [5, 6], referred to simply as 3’-O-NH2-SS-dATP (11), 
which has been characterized by HRMS. The ROX-NHS ester was conjugated to 3’-NH2 group to 
form the final compound 3’-O-ROX-SS-dATP (12), which has been characterized by HRMS. For 
the PEG-elongated linker, the ROX-PEG4-NHS ester was conjugated to the linker to form the final 





Scheme 2-2. Synthesis of 3’-O-ROX-SS-dATP (12) and 3’-O-ROX-PEG4-SS-dATP (13). 
 
N4-benzoyl-3’-O-methylthiomethyl-5'-O-tert-butyldimethylsilyl-2'-deoxyadenosine (8) 
N4-benzoyl-5'-O-tert-butyldimethylsilyl-2'-deoxyadenosine (1.41g, 3 mmol) was dissolved in 10 
mL anhydrous DMSO, followed by addition of 3 mL acetic acid, stirring at r.t. for 30 minutes. 
Then, 9 mL acetic anhydride was added dropwise to the reaction, stirring at r.t. for 2 days. After 
the reaction was complete (as monitored by TLC), the reaction was quenched by slow addition of 
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saturated NaHCO3 aqueous solution with vigorous stirring and extracted with 30 mL ethyl acetate 
three times. The combined organic layers were dried over anhydrous sodium sulfate (Na2SO4). 
After removing the solvent, the residue was purified by flash column chromatography on silica gel 
(DCM:methanol = 30:1) to give 1.39 g pure N4-benzoyl-3’-O-methylthiomethyl-5'-O-tert-
butyldimethylsilyl-2'-deoxyadenosine (8) (88%). 1H NMR (400 MHz, DMSO-d6): δ 0.06 (s, 6H), 
0.87 (s, 9H), 2.15 (s, 3H), 2.57 - 2. 62 (m, 1H), 2.95 - 3.02 (m, 1H), 3.72-3.76 (m, 1H), 3.81-3.86 
(m, 1H), 4.09 (s, 1H), 4.63 - 4.65 (m, 1H), 4.78 (s, 2H), 6.46 (t, J = 6.4 Hz, 1H), 7.54-7.680 (m, 
3H), 8.04-8.08 (m, 2H), 8.63 (s, 1H), 8.76 (s, 1H), 11.17(s, 1H); 13C NMR (100 MHz, DMSO-
d6 ): -5.02, -5.00, 13.78, 18.41,  26.23, 36.07, 63.38, 73.16, 76.56, 84.37, 85.17, 126.33, 128.92, 
128.96, 132.91, 133.83, 143.23, 150.88, 152.11, 152.42, 166.08; HRMS (ESI+) m/z calculated for 




N4-benzoyl-3’-O-methylthiomethyl-5'-O-tert-butyldimethylsilyl-2'-deoxyadenosine (8, 550 mg, 
1.04 mmol) was dissolved in 20 mL anhydrous dichloromethane, followed by addition of 0.3 mL 
cyclohexene and 2 g molecular sieves (3 Å), stirring under argon at r.t. for 30 minutes. The mixture 
was cooled in an ice-water bath, and then a fresh solution of sulfuryl chloride (0.12 mL, 1.50 mmol) 
in 3 mL anhydrous dichloromethane was added dropwise over 2 minutes. The ice bath was 
removed and the reaction mixture was stirred further for 30 minutes. The solvent was removed 
under reduced pressure, and then dried under high vacuum for 10 minutes. The mixture was 
redissolved in 10 mL anhydrous DMF, followed by addition of 0.61 g potassium p-
toluenethiosulfonate, stirring under argon at r.t. for 1 hour. A solution of 302 mg 2,2,2-trifluoro-
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N-(2-mercapto-2-methylpropyl)acetamide (1) was added to the reaction mixture, stirring under 
argon at r.t. for 3 hours. Then the reaction mixture was quickly filtered through Celite®. The filter 
was washed with dichloromethane and the organic fraction was concentrated to give crude N4-
benzoyl-3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl)-5'-O-tert-butyl- 
dimethylsilyl-2'-deoxyadenosine (9): MS (APCI+) m/z calculated for C30H41F3N6O5S2Si: 714.2310, 
found: 714.6. Without isolation, the crude compound 9 was dissolved in 10 mL THF, followed by 
addition of a 1.0 mL solution of 1.0 M TBAF in THF. After reaction was complete (as monitored 
by TLC), the solvent was reduced in vacuo, followed by addition of 50 mL saturated NaHCO3 
aqueous solution. The mixture was extracted with 100 mL dichloromethane twice. The organic 
layers were dried over anhydrous sodium sulfate (Na2SO4). After removing the solvent, the residue 
was purified by flash column chromatography on silica gel (DCM:methanol = 20:1) to give 128 
mg N4-benzoyl-3’-O-((1,1-dimethyl-2-trifluoroacet amidoethyl)disulfanylmethyl)-2'-deoxy- 
adenosine (10) (20% from compound 8). 1H NMR (400 MHz, DMSO-d6): δ 1.27 (s, 6H), 2.59 - 2. 
64 (m, 1H), 2.91 - 2.98 (m, 1H), 3.40-3.41(m,  2H), 3.58-3.68 (m, 2H), 4.10-4.13 (m, 1H), 4.61 - 
4.62 (t, J = 2.8 Hz, 1H), 4.98 (t, J = 12 Hz, 2H), 5.14 (t, J = 5.2 Hz, 1H), 6.44-6.47 (m, 1H), 7.54-
7.58 (m, 2H), 7.64-7.68 (m, 1H), 8.04-8.06 (m, 2H), 8.69 (s, 1H), 8.75 (s, 1H), 9.48 (t, J = 6.4 Hz, 
1H), 11.17 (s, 1H); 13C NMR (100 MHz, DMSO-d6 ): 25.66, 36.57, 48.41, 50.71, 61.98, 78.83, 
80.20, 84.37, 85.67, 116.50 (q, J = 286 Hz), 126.36, 128..94, 132.93, 133.81, 143.48, 150.88, 
152.07, 152.42, 157.37 (q, J = 36 Hz), 166.09; 19F NMR (376 MHz, DMSO-d6 ): -73.04; HRMS 





3’-O-((2-amino-1,1-dimethylethyl)disulfanylmethyl)-dATP (3’-O-NH2-SS-dATP) (11) 
N4-benzoyl-3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl)-2'-deoxyadenosine 
(10) (50 mg, 0.10 mmol), tributylammonium pyrophosphate (150 mg, 0.27 mmol) and 2-chloro-
4-H-1,3,2-benzodioxaphosphorin-4-one (33 mg, 0.17 mmol) were dried separately under high 
vacuum over P2O5 overnight at ambient temperature. The tributylammonium pyrophosphate was 
dissolved in 1 mL anhydrous DMF under argon, followed by addition of 1.5 mL tributylamine. 
The mixture was added into a solution of 2-chloro-4-H-1,3,2-benzodioxaphosphorin-4-one in 2 
mL anhydrous DMF, stirring under argon at r.t. for 1 hour. Then, the reaction mixture was added 
to the solution of N4-benzoyl-3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl)-
2'-deoxyadenosine (10) in 2 mL anhydrous DMF, stirring at r.t. for another 1 hour. Iodine solution 
(0.02 M iodine/ pyridine/ water) was added into the reaction mixture until a permanent brown 
color was observed, stirring for 10 minutes. 30 mL of water was added to the reaction mixture, 
stirring at r.t. for an additional 2 hours. Then, 30 mL of concentrated ammonium hydroxide 
(NH4OH) was added and the reaction was stirred at r.t. overnight. After volatiles were reduced 
under vacuum, the reaction mixture was extracted with 50 mL ethyl acetate. The aqueous layer 
was collected, followed by lyophilization to remove water, leaving a white solid. The solid was 
eluted by fresh ion-exchange chromatography on a DEAE-Sephadex A-25 column at 4°C with 
TEAB buffer in a concentration gradient from 0.1 M to 1.0 M. The crude product was further 
purified by reverse phase HPLC to give 3’-O-NH2-SS-dATP (11); HRMS (ESI-) m/z calculated 





3’-O-SS-ROX-dATP (12)  
3’-O-NH2-SS-dATP (11) (1.9 mg, 3.0 μmol) was dissolved in 0.3 mL 0.1 M NaHCO3/Na2CO3 
buffer (pH 8.9), followed by addition of a solution of 2.0 mg ROX-NHS ester in 0.2 mL anhydrous 
DMF, stirring at r.t. for 3 hours with exclusion of light. The crude product was then purified by 
fresh ion-exchange chromatography on a DEAE-Sephadex A-25 column at 4°C with TEAB buffer 
in a concentration gradient from 0.1 M to 1.0 M, and further purified by reverse phase HPLC to 
afford 3’-O-ROX-SS-dATP (12), which was characterized by HRMS (ESI-); m/z calculated for 
C48H55N8O16P3S2 [(M-H)-]:  1155.2312, found: 1155.2294.  
 
3’-O-ROX-PEG4-SS-dATP (13)  
ROX-PEG4-Acid (2.6 mg, 3.3 μmol) was dissolved in 0.2 mL anhydrous DMF, followed by 
addition of 0.9 mg N,N-disuccinimidyl carbonate and 0.43 mg 4-dimethylaminopyridine, stirring 
at r.t. for 2 hours. After complete conversion to ROX-PEG4-NHS ester (as monitored by TLC), 
the reaction mixture was directly used for coupling by mixing with a solution of 3’-O-NH2-SS-
dATP (11) (2.2 mg, 3.5 μmol) in 0.3 mL 0.1 M NaHCO3/Na2CO3 buffer (pH 8.9), stirring at r.t. 
for 3 hours with exclusion of light. The crude product was then purified by fresh ion-exchange 
chromatography on a DEAE-Sephadex A-25 column at 4°C with TEAB buffer in a concentration 
gradient from 0.1 M to 1.0 M, and further purified by reverse phase HPLC to afford 3’-O-ROX-
PEG4-SS-dATP (13), which was characterized by HRMS (ESI-); m/z calculated for 




2.2.3. Synthesis of 3’-O-Biotin-SS-dCTP and 3’-O-Biotin-PEG4-SS-dCTP 
 
The 3’-O-reversible anchor modified nucleotides, 3’-O-Biotin-SS-dCTP (19) and 3’-O-Biotin-
PEG4-SS-dCTP (20), have been designed to be potential anchor modified NRTs for SBS. The 
synthetic procedures for each intermediate, which follow or are modified from synthetic 
approaches in the literature, are provided as Scheme 3-3. First, the N4-benzoyl-2'-deoxycytidine 
was converted to N4-benzoyl-5'-O-tert-butyldiphenylsilyl-2'-deoxycytidine (14), which further 
reacted with DMSO, acetic acid and acetic anhydride to form N4-benzoyl-3’-O-methylthiomethyl-
5'-O-tert-butyldiphenylsilyl-2'-deoxycytidine (15) [2]. Treating with sulfuryl chloride, potassium 
p-toluenethiosulfonate, and the prepared thio compound (1) in order forms N4-benzoyl-3’-O-((1,1-
dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl)-5'-O-tert-butyldiphenylsilyl-2'-
deoxycytidine (16). After the tert-butyldiphenylsilyl protecting group was removed with 1.0M 
TBAF in THF to regenerate the 5’ hydroxyl group [7], N4-benzoyl-3’-O-((1,1-dimethyl-2-
trifluoroacetamidoethyl)disulfanylmethyl)-2'-deoxycytidine (17) was formed. The 2'-
deoxycytidine derivative was reacted with 2-chloro-4-H-1,3,2-benzodioxaphosphorin-4-one and 
tributylammonium pyrophosphate, following by treatment with ammonium hydroxide to produce 
3’-O-NH2-SS-dCTP (18) [5, 6], which has been characterized by HRMS. To synthesize anchor 
modified nucleotide, the Biotin-NHS ester was conjugated to the linker to form the final compound 
3’-O-Biotin-SS-dTTP (19), which has been characterized by HRMS. For the PEG4 elongated 
linker, the Biotin-PEG4-NHS ester was conjugated to the linker to form the final compound 3’-O-








A mixture of imidazole (1.36g, 20 mmole), tert-butyldiphenylsilyl chloride (2.86 mL, 11 mmole), 
and N4-benzoyl-2'-deoxycytidine (3.31 g, 10 mmole) was dissolved in 25 mL anhydrous DMF, 
stirring at r.t. for 24 hours. After the reaction was complete, 100 mL water was added to quench 
the reaction. The reaction mixture was extracted with 100 mL ethyl acetate, and then dried over 
anhydrous sodium sulfate (Na2SO4). Concentration and purification by flash column 
chromatography on silica gel (DCM:methanol = 10:1) gave pure N4-benzoyl-5'-O-tert-
butyldiphenylsilyl-2'-deoxycytidine (14) (4.16 g , 73 %). 1H NMR (400 MHz, DMSO-d6): δ 1.03 
(s, 9H), 2.11 - 2.18 (m, 1H), 2.36 – 2.43 (m, 1H), 3.80-3.84 (m, 1H), 3.93-3.99 (m, 2H), 4.30 - 
4.35 (m, 1H), 5.37-5.39 (m, 1H), 6.17 (t, J = 6.0 Hz, 1H), 7.23 (d, J= 6.4 Hz, 1H), 7.43-7.54 (m, 
8H), 7.60-17.67 (m, 5H), 7.99-8.01 (m, 2H), 8.24 (d, J=7.2 Hz, 1H), 11.24 (s, 1H); 13C NMR (100 
MHz, DMSO-d6 ): 19.27,  27.15, 41.31, 63.98, 69.79, 86.57, 87.49, 96.43, 128.46, 128.48, 
128.89, 128.92, 130.50, 130.52, 132.86, 133.10, 133.18, 135.51, 135.63, 144.81, 154.76, 163.47, 
167.77; MS (APCI+) m/z calculated for C18H33N2O5SSi [(M+H)+]: 570.2424, found: 570.41. 
 
N4-benzoyl-3’-O- methylthiomethyl -5'-O-tert-butyldiphenylsilyl-2'-deoxycytidine (15) 
N4-benzoyl-5'-O-tert-butyldiphenylsilyl-2'-deoxycytidine (14) (1.71 g, 3 mmol) was dissolved in 
10 mL anhydrous DMSO, followed by addition of 3 mL acetic acid, stirring at r.t. for 30 minutes. 
Then, 9 mL acetic anhydride was added dropwise to the reaction, stirring at r.t. for 2 days. After 
the reaction was complete (as monitored by TLC), the reaction was quenched by slow addition of 
saturated NaHCO3 aqueous solution under vigorous stirring and extracted with 30 mL ethyl acetate 
three times. The combined organic layers were dried over anhydrous sodium sulfate (Na2SO4). 
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After removing the solvent, the residue was purified by flash column chromatography on silica gel 
(DCM:MeOH = 1:30) to give pure N4-benzoyl-3’-O-methylthiomethyl-5'-O-tert-
butyldiphenylsilyl-2'-deoxycytidine (15) (1.57 g, 83%). 1H NMR (400 MHz, DMSO-d6): δ 1.04 (s, 
9H), 2,08 (s, 3H), 2.21 - 2.28 (m, 1H), 2.55 – 2.57 (m, 1H), 3.80-3.84 (m, 1H), 4.14-4.15 (m, 1H), 
4.54 - 4.56 (m, 1H), 4.72 (s, 2H), 6.14 (t, J = 6.4Hz, 1H), 7.24 (d, J = 6.0 Hz, 1H), 7.44-7.54 (m, 
8H), 7.61-7.67 (m, 5H), 8.00-8.02 (m, 2H), 8.21 (d, J = 7.6 Hz, 1H), 11.27 (s, 1H); 13C NMR (100 
MHz, DMSO-d6 ): 13.76, 19.24,  27.14, 38.13, 63.90, 73.38, 75.60, 85.00, 86.82, 96.62, 128.46, 
128.72, 128.90, 128.93, 130.54, 130.57, 132.76, 132.97, 133.20, 133.60, 135.53, 135.62, 144.78, 





N4-benzoyl-3’-O-methylthiomethyl-5'-O-tert-butyldiphenylsilyl-2'-deoxycytidine (15) (1.08 g, 
1.72 mmole) was dissolved in 20 mL anhydrous dichloromethane, followed by addition of 0.5 mL 
cyclohexene and 2 g molecular sieves (3 Å), stirring under argon at r.t. for 30 minutes. The mixture 
was cooled in an ice-water bath, and then a fresh solution of sulfuryl chloride (0.20 mL, 2.5 mmol) 
in 3 mL anhydrous dichloromethane was added dropwise during 2 minutes. The ice-bath was 
removed and the reaction mixture was stirred further for 30 minutes. The solvent was removed 
under reduced pressure, and then dried under high vacuum for 10 minutes. The mixture was 
redissolved in 10 mL anhydrous DMF, followed by addition of 1.0 g potassium p-
toluenethiosulfonate, stirring under argon at r.t. for 1 hour. A solution of 498 mg 2,2,2-trifluoro-
N-(2-mercapto-2-methylpropyl)acetamide (1) was added to the reaction mixture, stirring under 
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argon at r.t. for 3 hours. Then the reaction mixture was quickly filtered through Celite®. The filter 
was washed with dichloromethane and the organic fraction was concentrated to give crude N4-
benzoyl-3’-O-((1,1-dimethyl-2-trifluoro acetamidoethyl) disulfanylmethyl)-5'-O-tert-butyl 
diphenylsilyl-2'-deoxycytidine (16): MS (APCI+) m/z calculated for C29H41F3N4O6S2Si: 691.2267, 
found: 691.46. Without isolation, the crude compound 16 was dissolved in 10 mL of THF, 
followed by addition of a 2.0 mL solution of 1.0 M TBAF in THF. After reaction was complete 
(as monitored by TLC), the solvent was reduced in vacuo, followed by addition of 50 mL saturated 
NaHCO3 aqueous solution. The mixture was extracted with 100 mL DCM twice. The organic 
layers were dried over anhydrous sodium sulfate (Na2SO4). After removing the solvent, the residue 
was purified by flash column chromatography on silica gel (DCM:methanol = 20:1) to give N4-
benzoyl-3’-O-((1,1-dimethyl-2-trifluoro- acetamidoethyl)disulfanylmethyl)-2'-deoxycytidine (17) 
(171 mg, 17% from compound 17). 1H NMR (400 MHz, DMSO-d6): δ 1.26 (s, 6H),  2.15 - 2.21 
(m, 1H), 3.38-3.39 (m, 2H), 3.60-3.69 (m, 2H), 4.11-4.12 (d, J = 2.8 Hz, 1H), 4.41 - 4.43 (m, 1H), 
4.93 (s, 2H), 5.16 (t, J = 5.0 Hz, 1H), 6.12 (t, J = 6.4Hz, 1H), 7.37 (d, J = 7.2 Hz, 1H), 7.50-7.54 
(m, 2H), 7.62-7.65 (m, 1H), 8.01-8.03 (m, 2H), 8.38 (d, J = 7.6 Hz, 1H), 9.47 (t, J = 6.4 Hz, 1H), 
11.22 (s, 1H); 13C NMR (100 MHz, DMSO-d6 ): 25.65, 38.39, 48.39, 50.69,  61.57, 78.29, 80.22, 
85.76, 86.89, 96.61, 116.50 (q, J = 286 Hz), 128.91, 133.20, 133.58, 135.53, 135.62, 145.41, 
154.86, 157.36 (q, J = 36 Hz), 163.60, 167.78; 19F NMR (376 MHz, DMSO-d6 ): -73.04; HRMS 






3'-O-NH2-SS-dCTP (18)  
N4-benzoyl-3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl)-2'-deoxycytidine 
(17) (50 mg, 87 μmol), tributylammonium pyrophosphate (140 mg, 0.25 mmol) and 2-chloro-4-
H-1,3,2-benzodioxaphosphorin-4-one (30 mg, 0.15 mmol) were dried separately under high 
vacuum over P2O5 overnight at ambient temperature. The tributylammonium pyrophosphate was 
dissolved in 1 mL anhydrous DMF under argon, followed by addition of 1.5 mL tributylamine. 
The mixture was added into a solution of 2-chloro-4-H-1,3,2-benzodioxaphosphorin-4-one in 2 
mL anhydrous DMF, stirring under argon at r.t. for 1 hour. Then, the reaction mixture was added 
to the solution of N4-benzoyl-3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl)-
2'-deoxycytidine (17) in 2 mL anhydrous DMF, stirring at r.t. for another 1 hour. Iodine solution 
(0.02 M iodine/ pyridine/ water) was added into the reaction mixture until a permanent brown 
color was observed, further stirring for 10 minutes. 30 mL of water was added to the reaction 
mixture, stirring at r.t. for an additional 2 hours. Then, 30 mL ammonium hydroxide (NH4OH) 
was added and the reaction was stirred at r.t. overnight. After volatiles were removed under 
vacuum, the reaction mixture was extracted with 50 mL ethyl acetate. The aqueous layer was 
collected, followed by lyophilization to remove water, leaving a white solid. The solid was eluted 
by fresh ion-exchange chromatography on a DEAE-Sephadex A-25 column at 4°C with TEAB 
buffer in a concentration gradient from 0.1 M to 1.0 M. The crude product was further purified by 
reverse phase HPLC to give 3'-O-NH2-SS-dCTP (18), which was characterized by HRMS (ESI-); 





3'-O-Biotin-SS-dCTP (19)  
3'-O-NH2-SS-dCTP (18) (1.85 mg, 3.0μmol) was dissolved in 0.3 mL 0.1 M NaHCO3/Na2CO3 
buffer (pH 8.9), followed by addition of a solution of 2.0 mg Biotin-NHS ester in 0.2 mL 
anhydrous DMF, stirring at r.t. for 3 hours. The crude product was then purified by fresh ion-
exchange chromatography on a DEAE-Sephadex A-25 column at 4°C with TEAB buffer in a 
concentration gradient from 0.1 M to 1.0 M, and further purified by reverse phase HPLC to afford 
3'-O-Biotin-SS-dCTP (19), which was characterized by HRMS (ESI-); m/z calculated for 
C24H41N6O15P3S3 [(M+K-2H)-]: 879.0485, found: 879.0363. 
 
3'-O-Biotin-PEG4-SS-dCTP (20)  
3'-O-NH2-SS-dCTP (18) (1.85 mg, 3.0μmol) was dissolved in 0.3 mL 0.1 M NaHCO3/Na2CO3 
buffer (pH 8.9), followed by addition of a solution of 2.0 mg Biotin-PEG4-NHS ester in 0.2 mL 
anhydrous DMF, stirring at r.t. for 3 hours. The crude product was then purified by fresh ion-
exchange chromatography on a DEAE-Sephadex A-25 column at 4°C with TEAB buffer in a 
concentration gradient from 0.1 M to 1.0 M, and further purified by reverse phase HPLC to afford 
3'-O-Biotin-PEG4-SS-dCTP (20), which was characterized by HRMS (ESI-); m/z calculated for 






2.2.4. Synthesis of 3’-O-TCO-SS-dGTP and 3’-O-TCO-PEG4-SS-dGTP 
 
The 3’-O-reversible anchor modified nucleotides, 3’-O-TCO-SS-dGTP (27) and 3’-O-TCO-
PEG4-SS-dGTP (28), have been designed to be potential anchor modified NRTs for SBS. The 
synthetic procedures for each intermediate, which follow or are modified from synthetic 
approaches in the literature, are provided as Scheme 3-4. First, the amino and the 5’-OH of 2’-
deoxyguanosine were protected. 2’-deoxyguanosine was converted to N2-DMF-2'-
deoxyguanosine (21) and then N2-DMF-5’-O-DMTr-2'-deoxyguanosine (22), which further 
reacted with DMSO, acetic acid and acetic anhydride to from N2-DMF-3’-O-methylthiomethyl-
5’-O-DMTr-2'-deoxyguanosine (23) [2]. Addition of sulfuryl chloride, potassium p-
toluenethiosulfonate, and the prepared thio compound (1) in order formed N2-
dimethylaminomethylene-3’-O-methylthiomethyl-5’-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine 
(24). After the tert-butyldiphenylsilyl protecting group was removed with 1.0M TBAF in THF to 
regenerate the 5’ hydroxyl group [7], N2-DMF-3’-O-((1,1-dimethyl-2-
trifluoroacetamidoethyl)disulfanylmethyl)-2'-deoxyguanosine (25) was formed. The 2'- 
deoxyguanosine derivative reacted with 2-chloro-4-H-1,3,2-benzodioxaphosphorin-4-one and 
tributylammonium pyrophosphate, following by treatment with ammonium hydroxide to product 
3’-O-NH2-SS-dGTP (26) [5, 6], which has been characterized by HRMS. To synthesize anchor 
modified nucleotide, the TCO-NHS ester was conjugated to the linker to form the final compound 
3’-O-TCO-SS-dTTP (27), which has been characterized by HRMS. For the PEG4 elongated linker, 
the TCO-PEG4-NHS ester was conjugated to the linker to form the final compound 3’-O-TCO-




Scheme 2-4. Synthesis of 3’-O-TCO-SS-dGTP (27) and 3’-O-TCO-PEG4-SS-dGTP (28). 
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N2-dimethylformamidine-2'-deoxyguanosine (N2-DMF-2'-deoxyguanosine) (21) 
2’-deoxyguanosine (1g, 3.5 mmol) was dissolved in 10 mL anhydrous DMF, followed by addition 
of 2 mL of N,N-dimethylformamide dimethyl acetal, stirring at r.t. overnight. After the reaction 
was complete, the solvent was removed under high vacuum. The residue was washed by methanol 
and then water, followed by filtering through Celite®. The filter was dried under high vacuum to 
give 1.1 g pure N2-DMF-2'-deoxyguanosine (21) (92%). 1H NMR (400 MHz, DMSO-d6): δ 2.22 - 
2.26 (m, 1H), 2.56 - 2.63 (m, 1H), 3.04 (s, 3H), 3.17 (s, 3H), 3.49-3.61 (m, 2H), 3.83-3.85 (m, 1H), 
4.38 - 4.39 (m, 1H), 4.94 (t, J = 5.6 Hz, 1H), 5.29-5.30 (m, 1H), 6.24-6.27 (m, 1H), 8.04 (s, 1H), 
8.56 (s, 1H), 11.31 (s, 1H); 13C NMR (100 MHz, DMSO-d6 ): 35.11, 41.10, 62.29, 71.39, 83.25, 
88.19, 120.15, 137.13, 150.09, 157.73, 158.06, 158.45; HRMS (ESI+); m/z calculated for 





N2-DMF-2'-deoxyguanosine (21) (500 mg, 1.55 mmol) was dissolved in 10 mL anhydrous 
pyridine, followed by addition of 644 mg 4,4-dimethoxytrityl chloride (1.9 mmol), stirring at r.t. 
for 2 hours. The reaction was quenched by addition of water, followed by extraction with 200 mL 
of DCM, and dried over anhydrous sodium sulfate (Na2SO4). Concentration and purification by 
flash column chromatography on silica gel (dichloromethane:methanol = 20:1) gave N2-DMF-5’-
O-DMTr-2'-deoxyguanosine (22). 1H NMR (400 MHz, DMSO-d6): δ  2.28-2.34 (m, 1H), 2.65 - 
2.72 (m, 1H), 3.04 (s, 3H), 3.12 (s, 3H), 3.16-3.22 (m, 2H), 3.73 (s, 6H), 3.92-3.95 (m, 1H), 4.40 
- 4.42 (m, 1H), 5.38-5.37 (m, 1H), 6.24-6.31 (m, 1H), 6.80-6.86 (m, 4H), 7.20-7.27 (m, 7H), 7.33 
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(d, J = 6.8Hz, 2H), 7.93 (s, 1H), 8.52 (s, 1H), 11.37 (s, 1H); 13C NMR (100 MHz, DMSO-d6 ): 
35.13, 41.12, 55.47, 64.78, 71.14, 82.86, 85.90, 86.24, 113.24, 113.56, 120.26, 127.09, 128.14, 
128.21, 130.07, 130.15, 135.99, 136.03, 136.95, 145.35, 150.11, 157.65, 158.09, 158.33, 158.47, 
158.50; HRMS (ESI+) m/z calculated for C34H36N6O6 [(M+H)+]: 625.2775, found 625.2767. 
 
N2-dimethylformamidine-3’-O-methylthiomethyl-5’-O-(4,4'-dimethoxytrityl)-2'-
deoxyguanosine (N2-DMF-3’-O-methylthiomethyl-5’-O-DMTr-2'-deoxyguanosine) (23) 
 
N2-DMF-5’-O-DMTr-2'-deoxyguanosine (22, 1.31 g, 3 mmol) was dissolved in 10 mL anhydrous 
DMSO, followed by addition of 2.6 mL acetic acid, stirring at r.t. for 30 minutes. Then, 8.6 mL 
acetic anhydride was added dropwise to the reaction, stirring at r.t. for 2 days. After the reaction 
was complete (as monitored by TLC), the reaction was quenched by slow addition of saturated 
NaHCO3 aqueous solution under vigorous stirring and extracted with 30 mL ethyl acetate three 
times. The combined organic layers were dried over anhydrous sodium sulfate (Na2SO4). After 
removing the solvent, the residue was purified by flash column chromatography on silica gel 
(dichloromethane:methanol = 20:1) to give pure N2-DMF-3’-O-methylthiomethyl-5’-O-DMTr-2'-
deoxyguanosine (23) (56 %, 1.15 g). 1H NMR (400 MHz, DMSO-d6): δ 2.02 (s, 3H), 2.43-2.46 
(m, 1H), 2.79 - 2.90 (m, 1H), 3.04 (s, 3H), 3.11 (s, 3H), 3.19-3.20 (m, 2H), 3.73 (s, 6H), 3.98-4.00 
(m, 1H), 4.65 - 4.71 (m, 1H), 4.74 (s, 2H), 6.24 (t, J = 6.8 Hz, 1H), 6.81-6.85 (m, 4H), 7.20-7.35 
(m,  9H), 7.95 (s, 1H), 8.52 (s, 1H), 11.34 (s, 1H); 13C NMR (100 MHz, DMSO-d6 ): 13.65, 
35.14, 36.48, 55.48, 64.26, 73.39, 76.36, 83.26, 83.50, 86.11, 113.59, 120.41, 127.16, 128.12, 
128.24, 128.38, 130.04, 130.12, 135.92, 135.96, 137.12, 145.24, 150.07, 157.63, 158.06, 158.27, 
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N2-DMF-3’-O-methylthiomethyl-5’-O-DMTr-2'-deoxyguanosine (23, 1.0 g, 1.46 mmol) was 
dissolved in 20 mL anhydrous dichloromethane, followed by addition of 0.42 mL cyclohexene and 
2 g molecular sieves (3 Å), stirring under argon at r.t. for 30 minutes. The mixture was cooled in 
an ice-water bath, and then a 0.17 mL fresh solution of sulfuryl chloride in 3 mL anhydrous 
dichloromethane was added dropwise over 2 minutes. The ice bath was removed and the reaction 
mixture was stirred further for 30 minutes. The solvent was removed under reduced pressure, and 
then dried under high vacuum for 10 minutes. The mixture was redissolved in 10 mL anhydrous 
DMF, followed by addition of 1.0 g of potassium p-toluenethiosulfonate, stirring under argon at 
r.t. for 1 hour. A solution of 423 mg 2,2,2-trifluoro-N-(2-mercapto-2-methylpropyl)acetamide (1) 
was added to the reaction mixture, stirring under argon at r.t. for 3 hours. Then the reaction mixture 
was quickly filtered through Celite®. The filter was washed with dichloromethane and the organic 
fraction was concentrated to give crude N2-DMF-3’-O-((1,1-dimethyl-2-
trifluoroacetamidoethyl)disulfanylmethyl)-5’-O-DMTr-2'-deoxyguanosine (24): MS (APCI+) m/z 
calculated for C41H46F3N7O7S2: 870.2930, found: 870.5.  Without isolation, the crude compound 
24 was dissolved in 10 mL dichloromethane, followed by the addition of a 10 mL solution of 5% 
trifluoroacetic acid in dichloromethane. After reaction was complete (as monitored by TLC), the 
solvent was reduced in vacuo, followed by addition of 50 mL saturated NaHCO3 aqueous solution. 
The mixture was extracted with 100 mL DCM twice. The organic layers were dried over anhydrous 
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sodium sulfate (Na2SO4). After removing the solvent, the residue was purified by flash column 
chromatography on silica gel (DCM:methanol = 20:1) to give N2-DMF-3’-O-((1,1-dimethyl-2-
trifluoroacetamido ethyl)disulfanylmethyl)-2'-deoxyguanosine (25) (165 mg, 20 % from 
compound 23). 1H NMR (400 MHz, DMSO-d6): δ 1.21 (s, 6H), 2.05-2.12 (m, 1H), 2.23 - 2.28 (m, 
1H), 3.03 (s, 3H), 3.16 (s, 3H), 3.86-3.89 (m, 1H), 4.26 - 4.27 (m, 1H), 4.87 (t, J = 5.2 Hz, 1H), 
5.13-5.17 (m, 1H), 5.62-5.69 (s, 2H), 8.20 (s, 1H), 8.63 (s, 1H), 9.45 (s, 1H), 11.50 (s, 1H); 13C 
NMR (100 MHz, DMSO-d6 ): 25.56, 25.72, 35.01, 38.49, 48.32, 50.58, 62.05, 73.69, 78.87, 
86.54, 91.32, 116.49 (q, J = 286 Hz), 120.78, 144.72, 155.70, 157.32 (q, J = 36 Hz), 157.34, 158.06, 




(25) (50 mg, 88 μmol), tributylammonium pyrophosphate (140 mg, 0.25 mmol) and 2-chloro-4-
H-1,3,2-benzodioxaphosphorin-4-one (30 mg, 0.15 mmol) were dried separately under high 
vacuum over P2O5 overnight at ambient temperature. The tributylammonium pyrophosphate was 
dissolved in 1 mL anhydrous DMF under argon, followed by addition of 1.5 mL of tributylamine. 
The mixture was added into a solution of 2-chloro-4-H-1,3,2-benzodioxaphosphorin-4-one in 2 
mL anhydrous DMF, stirring under argon at r.t. for 1 hour. Then, the reaction mixture was added 
to the solution of N2-DMF-3’-O-((1,1-dimethyl-2-trifluoroacetamidoethyl)disulfanylmethyl)-2'-
deoxyguanosine (25) in 2 mL anhydrous DMF, stirring at r.t. for another 1 hour. Iodine solution 
(0.02 M iodine/ pyridine/ water) was added into the reaction mixture until a permanent brown 
color was observed, stirring for 10 minutes. 30 mL water was added to the reaction mixture, stirring 
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at r.t. for an additional 2 hours. Then, 30 mL of concentrated ammonium hydroxide (NH4OH) was 
added and the reaction was stirred at r.t. overnight. After volatiles were removed under vacuum, 
the reaction mixture was extracted with 50 mL ethyl acetate. The aqueous layer was collected, 
followed by lyophilization to remove water, leaving a white solid. The solid was eluted by fresh 
ion-exchange chromatography on a DEAE-Sephadex A-25 column at 4°C with TEAB buffer in a 
concentration gradient from 0.1 M to 1.0 M. The crude product was further purified by reverse 
phase HPLC to give 3’-O-NH2-SS-dGTP (26), which was characterized by HRMS (ESI-); m/z 
calculated for C15H27N6O13P3S2 [(M-H)-]: 655.0212, found: 655.0212. 
 
3'-O-TCO-SS-dGTP (27) 
3’-O-NH2-SS-dGTP (26) (2.0 mg, 3.0 μmol) was dissolved in 0.3 mL 0.1 M NaHCO3/Na2CO3 
buffer (pH 8.9), followed by addition of a solution of 1.0 mg of TCO-NHS ester in 0.2 mL 
anhydrous DMF, stirring at r.t. for 3 hours. The crude product was then purified with fresh ion-
exchange chromatography on a DEAE-Sephadex A-25 column at 4°C with TEAB buffer in a 
concentration gradient from 0.1 M to 1.0 M, and further purified by reverse phase HPLC to afford 
3'-O-TCO-SS-dGTP (27), which was characterized by HRMS (ESI-); m/z calculated for 
C24H39N6O15P3S2[(M-H)-]:  807.1049, found: 807.1057. 
 
3'-O-TCO-PEG4-SS-dGTP (28) 
3’-O-NH2-SS-dGTP (26) (2.0 mg, 3.0 μmol) was dissolved in 0.3 mL 0.1 M NaHCO3/Na2CO3 
buffer (pH 8.9), followed by addition of a solution of 1.6 mg TCO-PEG4-NHS ester in 0.2 mL 
anhydrous DMF, stirring at r.t. for 3 hours. The crude product was then purified by fresh ion-
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exchange chromatography on a DEAE-Sephadex A-25 column at 4°C with TEAB buffer in a 
concentration gradient from 0.1 M to 1.0 M, and further purified by reverse phase HPLC to afford 
3'-O-TCO-PEG4-SS-dGTP (28), which was characterized by HRMS (ESI-); m/z calculated for 
C38H60N7O20P3S2 [(M-H)-]: 1054.2469, found: 1054.2480. 
 
2.3. Incorporation and Cleavage Performances of the Synthesized 3’-O-SS-Cleavable 
Fluorescent/Anchor Modified NRTs  
To investigate the performance of the synthesized 3’-O-SS-cleavable fluorescent/anchor 
nucleotide analogues as reversible terminators, the incorporation efficiency of nucleotides in the 
polymerase reaction was demonstrated in solution. Reactions were carried out in solution with one 
of eight synthesized 3’-O-SS-cleavable fluorescent/anchor modified nucleotides (3’-O-ROX-SS-
dATP, 3’-O-ROX-PEG4-SS-dATP, 3’-O-BodipyFL-SS-dTTP, 3’-O-BodipyFL-PEG4-SS-dTTP, 
3’-O-Biotin-SS-dCTP, 3’-O-Biotin-PEG4-SS-dCTP, 3’-O-TCO-SS-dGTP or 3’-O-TCO-PEG4-
SS-dGTP), TherminatorTM IX DNA polymerase, and cofactor ions. DNA primers were 
synthesized along with the corresponding templates in which one base (A, T, C, or G) is expected 
to be incorporated opposite the base in the next template position at the 3’ end of the primer. After 
the incorporation, cleavage reactions to remove the 3’-O-SS-cleavable linker and regenerate the 
3’-OH group were performed and characterized by treating with THP. 
 
Incorporation reactions were carried out for 3’-O-SS-fluorescent modified nucleotide 
analogues without the PEG linker, 3’-O-ROX-SS-dATP and 3’-O-BodipyFL-SS-dTTP, as well as 
those with the PEG-elongated linker, 3’-O-ROX-PEG4-SS-dATP and 3’-O-BodipyFL-PEG4-SS-
dTTP, to extend the DNA primer produce extension products with a fluorophore at the 3’ end of 
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the growing strand. The effect of the PEG-elongated linker on incorporation efficiency will be 
illustrated in the next chapter. The matrix assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF MS) analysis confirmed that TherminatorTM IX DNA polymerase with 
added Mn2+ results in excellent incorporation efficiency for all four examined 3’-O-SS-fluorescent 
modified nucleotide analogues. The enzymatic reactions resulted in complete incorporation of 3’-
O-ROX-SS-dATP, 3’-O-BodipyFL-SS-dTTP, 3’-O-ROX-PEG4-SS-dATP, and 3’-O-BodipyFL-
PEG4-SS-dTTP into the primer as evidenced by the single observed peaks in the mass spectra (MS) 
of 7064 Da (7065 Da expected) (see Figure 2-6(a)), 5885 Da (5893 Da expected) (see Figure 2-
7(a)), 7304 Da (7312 Da expected) (see Figure 2-8(a)) and 6140 Da (6140 Da expected) (see 
Figure 2-9(a)), respectively. Furthermore, the MALDI-TOF MS analysis confirmed that the THP 
treatment results in excellent cleavage efficiency for all four extension primer products from the 
corresponding examined nucleotides. The cleavage reaction resulted in complete removal of the 
linker from the 3’-O position as evidenced by single observed peaks in the respective mass spectra 
(MS) of 6391 Da (6400 Da expected) (see Figure 2-6(b)), 5464 Da (5470 Da expected) (see 
Figure 2-7(b)), 6400 Da (6400 Da expected) (see Figure 2-8(b)), and 5469 Da (5470 Da expected) 





Figure 2-6. Result of MALDI-TOF MS (right) characterization of single base extension with (a) 
3’-O-ROX-SS-dATP and its cleavage product (b) after treating with THP. Scheme (left) shows 
that the incorporation reaction for 3’-O-ROX-SS-dATP (1156 Da) to extend the primer (E8AA, 
6084 Da) produces extension product (1) (7064 Da), followed by addition of THP resulting in 
cleavage product (2) (6391 Da). 
 
 
Figure 2-7. Result of MALDI-TOF MS (right) characterization of single base extension with (a) 
3’-O-BodipyFL-SS-dTTP and its cleavage product (b) after treating with THP. Scheme (left) 
shows that the incorporation reaction for 3’-O-BodipyFL-SS-dTTP (905 Da) to extend the primer 
(E8TT, 5163 Da) produces extension product (1) (5885 Da), followed by addition of THP resulting 




Figure 2-8. Result of MALDI-TOF MS (right) characterization of single base extension with (a) 
3’-O-ROX-PEG4-SS-dATP and its cleavage product (b) after treating with THP. Scheme (left) 
shows that the incorporation reaction for 3’-O-ROX-PEG4-SS-dATP (1403 Da) to extend the 
primer (E8AA, 6084 Da) produces extension product (1) (7304 Da), followed by addition of THP 
resulting in cleavage product (2) (6400 Da). 
 
 
Figure 2-9. Result of MALDI-TOF MS (right) characterization of single base extension with (a) 
3’-O-BodipyFL-PEG4-SS-dTTP and its cleavage product (b) after treating with THP. Scheme (left) 
shows that the incorporation reaction for 3’-O-BodipyFL-PEG4-SS-dTTP (1152 Da) to extend the 
primer (E8TT, 5163 Da) produces extension product (1) (6140 Da), followed by addition of THP 
resulting in cleavage product (2) (5469 Da). 
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Incorporation reactions were performed for 3’-O-SS-cleavable anchor modified nucleotide 
analogues without the PEG linkage, 3’-O-Biotin-SS-dCTP and 3’-O-TCO-SS-dGTP, as well as 
with the PEG linkage, 3’-O-Biotin-PEG4-SS-dCTP and 3’-O-TCO-PEG4-SS-dGTP, to extend the 
DNA primer produce extension products with an anchor at the 3’ end of the growing strand. The 
MALDI-TOF MS analysis confirmed that TherminatorTM IX DNA polymerase with added Mn2+ 
results in excellent incorporation efficiency for 3’-O-TCO-SS-dGTP and 3’-O-SS-PEG4-TCO-
dGTP as evidenced by the single observed peak in the mass spectrum (MS) of 6765 Da (6764 Da 
expected) (see Figure 2-10(a)) and 7013 Da (7011 Da expected) (see Figure 2-11(a)), respectively. 
Furthermore, the MALDI-TOF MS analysis also confirmed that the THP treatment results in 
excellent cleavage efficiency for both extension primer products from the examined dGTP 
derivatized nucleotides. The cleavage reaction resulted in complete removal of the linker from the 
3’-O position of the dGTP incorporated growing strand as evidenced by single observed peaks in 
the respective mass spectra (MS) of 6463 Da (see Figure 2-10(b)) and 6468 Da (see Figure 2-
11(b)) (6463 Da expected). 
 
 On the other hand, the enzymatic reactions resulted in incomplete incorporation of 3’-O-
Biotin-SS-dCTP and 3’-O-Biotin-PEG4-SS-dCTP into the primer as evidenced by the presence of 
both the primer and the extension product peaks in the MALDI-TOF MS spectra. The 
incorporation of 3’-O-Biotin-SS-dCTP resulted in peaks in the mass spectrum (MS) of 5144 Da 
(the primer) and 5810 Da (5811 Da expected) (see Figure 2-12(a)); the incorporation of 3’-O-
Biotin-PEG4-SS-dCTP resulted in peaks in the mass spectrum (MS) of 5144 Da (the primer) and 
6055 Da (6058 Da expected) (see Figure 2-13(a)). The MALDI-TOF MS analysis confirmed that 
the TCP cleavage resulted in complete removal of the linker from the 3’-O position of the dCTP 
73 
 
incorporated growing strand as evidenced by the absence of both extension products in MS spectra 
for the examined dCTP derivatives. The cleavage reaction resulted in complete removal of the 
linker from the 3’-O position of the dCTP incorporated growing strand as evidenced by single 
observed peaks in the respective mass spectra (MS) of 5432 Da (see Figure 2-12(b)) and 5436 Da 
(see Figure 2-13(b)) (5436 Da expected), within the resolution of the instrument. However, the 
MALDI-TOF MS presented with extra peaks in the incorporation and cleavage reactions. The 
cleavage reaction for the 3’-O-Biotin-SS-dCTP incorporated extension primer product resulted in 
an extra peak in the mass spectrum of 4838 Da (see Figure 2-12(b)); the incorporation for the 3’-
O-Biotin-PEG4-SS-dCTP to extend the primer resulted in extra peaks in the mass spectrum of 5448 
Da, 4840 Da, and other minor peaks (see Figure 2-13(a)); and the subsequent cleavage reaction 
resulted in an extra peak in the mass spectrum of 4838 Da and other minor peaks (see Figure 2-
13(b)). Although these extra peaks were not identified, the molecular weights of the extra products 
are likely to be due to shortening of the primer strand by one or more bases, indicating that 
exonucleolytic events might occur in the incorporation and/or cleavage reactions with the 





Figure 2-10. Result of MALDI-TOF MS (right) characterization of single base extension with (a) 
3’-O-TCO-SS-dGTP and its cleavage product (b) after treating with THP. Scheme (left) shows 
that the incorporation reaction for 3’-O-TCO-SS-dGTP (808 Da) to extend the primer (E7GG, 
6131 Da) produces extension product (1) (6765 Da), followed by addition of THP resulting in 
cleavage product (2) (6463 Da). 
 
 
Figure 2-11. Result of MALDI-TOF MS (right) characterization of single base extension with (a) 
3’-O-TCO-PEG4-SS-dGTP and its cleavage product (b) after treating with THP. Scheme (left) 
shows that the incorporation reaction for 3’-O-TCO-PEG4-SS-dGTP (1055 Da) to extend the 
primer (E7GG, 6131 Da) produces extension product (1) (7013 Da), followed by addition of THP 




Figure 2-12. Result of MALDI-TOF MS (right) characterization of single base extension with (a) 
3’-O-Biotin-SS-dCTP and its cleavage product (b) after treating with THP. Scheme (left) shows 
that the incorporation reaction for 3’-O-Biotin-SS-dCTP (842 Da) to extend the primer (E8CC, 
5144 Da) produces extension product (1) (5810 Da), followed by addition of THP resulting in 
cleavage product (2) (5432 Da). An extra product (4838 Da) is produced in the cleavage reaction. 
 
 
Figure 2-13. Result of MALDI-TOF MS (right) characterization of single base extension with (a) 
3’-O-Biotin-PEG4-SS-dCTP and its cleavage product (b) after treating with THP. Scheme (left) 
shows that the incorporation reaction for 3’-O-Biotin-PEG4-SS-dCTP (1089 Da) to extend the 
primer (E8CC, 5144 Da) produces extension product (1) (6055 Da), followed by addition of THP 




General Approach for HPLC Chromatography  
The products were purified by reverse phase HPLC on a 150 x 4.6 mm C18 column (Waters, Xterra 
column), mobile phase: A, 8.6 mM triethylamine/ 100 mM hexafluoroisopropyl alcohol in water 
(pH=8.1); B, methanol. Elution was performed with 100% of A isocratic over 5 minutes, followed 
by linear gradients of 0 to 20% of B for 30 minutes, 20% to 80% of B for 25 minutes, and then 
80% to 100% of B for 10 minutes. 
 
General Approach for Polymerase Extension Reaction 
The extension reaction using individual synthesized nucleotide analogues was carried out using 20 
pmol of the template (Exon8 or Exon7, see Table 2-1), 60 pmol primer (E8AA, E8CC, E8TT, or 
E7GG, see Table 2-1), 100-200 pmol of nucleotide analogue, and 4 units of polymerase, in 20 l 
1X ThermoPolMT Reaction Buffer containing 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 
2 mM MgSO4, and 0.1% Triton® X-100, pH 8.8 @ 25OC. The reactions were conducted in an ABI 
GeneAmp PCR System 9700 with initial incubation at 65 OC for 30 second, followed by 38 cycles 
of 65 OC /30 sec, 45 OC /30 sec, 65 OC /30 sec. The reaction mixtures were desalted using Oligo 










Table 2-1. Template-Primer Pairs for Polymerase Extension Reaction. 
Incorporation 
Base 
Sequences of primer and template 
A incorporation 
 
The primer (E8AA, M.W. 6084) 
5’-TAGATGACCCTGCCTTGTCG-3’ 
 
The template (Exon8)* 
5’- GAAGGAGACACGCGGCCAGAGAGGGTCCTGTCCGTGTTTGTGCGTGGAGTTCGACA 




The primer (E8TT, M.W. 5163) 
5’-GATAGGACTCATCACCA-3’ 
 
The template (Exon8)* 
5’- GAAGGAGACACGCGGCCAGAGAGGGTCCTGTCCGTGTTTGTGCGTGGAGTTCGACA 




The primer (E8CC, M.W. 5144) 
5’-TCTCTGGCCGCGTGTCT-3’ 
 
The template (Exon8)* 
5’- GAAGGAGACACGCGGCCAGAGAGGGTCCTGTCCGTGTTTGTGCGTGGAGTTCGACA 




The primer (E7GG, M.W. 6131) 
5’-GTTGATGTACACATTGTCAA-3’ 
 
The template (Exon7)* 
5’- TACCCGGAGGCCAAGTACGGCGGGTACGTCCTTGACAATGTGTACATCAACATCA 
      CCTACCACCATGTCAGTCTCGGTTGGATCCTCTATTGTGTCCGGG- 3’ 
 
*The underlined sequence is a complementary sequence of each corresponding primer sequence. 
 
General Approach for Chemical Cleavage of NRTs   







2.4. Labeling of 3’-O-TCO-PEG4-SS-dGTP by Tetrazine-PEG4-TAMRA 
To investigate the reactivity of the anchor moieties, which were attached at the 3’ position of 
nucleotides, the efficiency of orthogonal conjugations of the synthesized 3’-O-SS-cleavable 
anchor modified nucleotides to the corresponding labeled binding molecules was demonstrated in 
solution. Two types of anchor moieties, biotin and TCO, have been successfully attached to the 3’ 
position of the modified dCTP and dGTP analogues via a dithiomethyl linker with or without the 
PEG-elongation, respectively. A TCO-tetrazine covalently bound product could be identified by 
mass spectroscopy, as described here, while the biotin-streptavidin affinity product was 
demonstrated on a chip (see chapter 3). Tetrazine ligation is an inverse-electron-demand Diels-
Alder reaction, in which tetrazine (a diene) reacts with a trans-cyclooctene (TCO) (a dienophile) 
with an unusually fast reaction rate without any catalysis (see Figure 2-14). The advantages of the 
reaction include the highly selective reactivity, the high yield over a broad range of reaction 
conditions, and the inert by-product (N2 gas) [8]. This reaction was carried out in solution with the 
synthesized 3’-O-TCO-PEG4-SS-dGTP and Tetrazine-PEG4-TAMRA to form the Alexa488 
labeled dGTP derivatized product (see Scheme 2-5), which has been characterized by MALDI-
TOF MS, 1881 Da (m/z) (1875 Da expected) (see Figure 2-15).  The result indicted that the anchor, 
TCO, of 3’-O-TCO-PEG4-SS-dGTP displayed high reactivity with Tetrazine-PEG4-TAMRA, 
illustrating that the TCO-tetrazine ligation with 3’-O-TCO-SS-modified nucleotide analogues 








Figure 2-14. The mechanism of inverse-type Diels-Alder between TCO and TZ. 
 
TAMRA labeled dGTP derivative 
Tetrazine-PEG4-TAMRA (200 pmol) was added to 3’-O-TCO-SS-dGTP (20 pmol) in water, 
stirring at r.t. for 5 minutes. The resulting mixture was directly detected by mass spectroscopy. 
The TAMRA labeled dGTP derivative was characterized by MS (MALDI-TOF); m/z calculated 
for C80H112N13O29P3S2: 1875.6343, found: 1881. 
 
 
Scheme 2-5. Reaction of 3’-O-TCO-PEG4-SS-dGTP and Tetrazine-PEG4-TAMRA to form the 





Figure 2-15. MALDI-TOF MS result for reaction of 3’-O-TCO-PEG4-SS-dGTP (1063 Da 
detected) and Tetrazine-PEG4-TAMRA (855 Da detected). The TAMRA labeled dGTP 
derivatized conjugation product was produced as indicated by the peak at 1881 Da. 
 
2.5. Summary 
To develop the set of 3’ reversibly fluorescent labeled nucleotides for scarless SBS, nucleotide 
analogues with directly attached fluorescent dyes for two of the four bases (i.e., A and T) and 
nucleotide analogues with directly attached anchors for the other two of the four bases (i.e. C and 
G) have been constructed, along with dye-labeled anchor binding molecules. For demonstration of 
the 4-color SBS approach, 3’-O-SS-cleavable fluorescent/anchor modified NRTs (3’-O-ROX-SS-
dATP, 3’-O-BodipyFL-SS-dTTP, 3’-O-Biotin-SS-dCTP and 3’-O-TCO-SS-dGTP) have been 
successfully synthesized; to take advantage of their potentially higher incorporation efficiency (see 
section 3.2), 3’-O-SS-cleavable fluorescent/anchor modified NRTs with a PEG-elongated linker 
(3’-O-ROX-PEG4-SS-dATP, 3’-O-BodipyFL-PEG4-SS-dTTP, 3’-O-Biotin-PEG4-SS-dCTP and 
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3’-O-TCO-PEG4-SS-dGTP) also have been synthesized. The incorporation and cleavage reactions 
of all synthesized 3’-O-modified dNTPs indicated that 3’-O-ROX-SS-dATP, 3’-O-BodipyFL-SS-
dTTP, 3’-O-TCO-SS-dGTP, 3’-O-ROX-PEG4-SS-dATP, 3’-O-Biotin-PEG4-SS-dCTP and 3’-O-
TCO-PEG4-SS-dGTP all displayed excellent incorporation and cleavage efficiencies, while 3’-O-
Biotin-SS-dCTP and 3’-O-Biotin-PEG4-SS-dCTP showed incomplete incorporation in the 
enzymatic reactions and extra MS peaks following incorporation and/or cleavage reactions. 
Although these extra peaks were not identified, the sizes of the extra products suggest that 
exonucleolytic events might occur during the incorporation and/or cleavage reactions. Moreover, 
the 3’-O-TCO-PEG4-SS-dGTP has been successfully labeled with Tetrazine-PEG4-TAMRA, 
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Chapter 3 Development of Chip Based SBS Assays Using 4-Color 3’-O-SS-
Cleavable Fluorescent/Anchor Modified NRTs 
 
3.1. Introduction 
In developing a protocol for scarless SBS using the synthesized 3’-O-SS-cleavable 
fluorescent/anchor modified NRTs, several different parameters have to been considered and 
tested. The reaction rate for incorporation of these nucleotide analogues is a major consideration, 
both for individual nucleotides and for comparisons between nucleotides of interest. Although 
prior tests (see chapter 2) with synthesized 3’-O-modified nucleotides proved that each of them 
could be incorporated with sufficiently long reaction times (38 cycles with 30 sec extension steps), 
the individual and competitive performance of their incorporation efficiencies over shorter reaction 
times (5 cycles) is studied in this chapter.  First, the incorporation efficiency of a 3’-O-modified 
nucleotide with a PEG linker relative to one without a PEG linker has been investigated. Second, 
the incorporation efficiency of a 3’-O-modified nucleotide with a PEG linker relative to one 
without a reporter (3’-O-tert-butyldithiomethyl-dNTP; 3’-O-tert-Butyl-SS-dNTP) has been 
investigated in various concentration combinations. Moreover, to further understand the potential 
of using the 3’-O-SS-cleavable fluorescent/anchor modified NRTs for SBS, a set of four of the 3’-
O-SS-cleavable fluorescent/anchor nucleotide analogues for four different bases was selected and 
these were applied to obtain a continuous four base sequence in solution. 
 
To further apply the synthesized 3’-O-SS-cleavable fluorescent/anchor modified NRTs to SBS 
on-chip, we first conducted SBS with two 3’-O-SS-cleavable fluorescent modified NRTs, where 
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only A and T could be detected with fluorescent signals and C and G are silent. Next, we conducted 
four-color SBS using a combination of two 3’-O-SS-cleavable fluorescent modified NRTs and two 
3’-O-SS-cleavable anchor modified NRTs. Both lab-scale DNA sequencing proof-of-principle 
experiments identified 7 continuous bases using DNA templates immobilized on a chip.  
 
3.2. Incorporation Comparison of 3’-O-SS-Cleavable Fluorescent/Anchor Modified 
NRTs with and without a PEG Linker 
 
3.2.1. Investigation of Reaction Rate of 3’-O-ROX-SS-dATP Incorporation 
Although the incorporation performances of synthesized 3’-O-SS-cleavable fluorescent 
modified NRTs have been demonstrated using single base extension in solution in chapter 2, it 
was of interest to determine how fast the nucleotides could be incorporated. Incorporation 
reactions were performed for different reaction times (varying number of PCR cycles). Reactions 
were carried out in solution with 3’-O-ROX-SS-dATP, TherminatorTM IX DNA polymerase, and 
cofactor ions. Three reaction batches were set up and subjected to either 5, 10, or 30 PCR cycles. 
The MALDI-TOF MS analysis shows that more than 50% of the primers were extended with 3’-
O-ROX-SS-dATP by the 5th cycle; about 80% of the primers were extended by the 10th cycle; 
and primer was completely extended by the 30th cycle (see Figure 3-1). The yield of the 3’-O-
ROX-SS-dATP incorporated extension products with different number of cycles was considered 




Figure 3-1. MALDI-TOF MS results for extension reaction using 3’-O-ROX-SS-dATP for 5, 10, 
and 30 cycles.  More than 50% of the primers were extended with 3’-O-ROX-SS-dATP by the 5th 
cycle. About 80% of the primers were extended by the 10th cycle, and primer was completely 
extended by the 30th cycle. 
 
 
Polymerase Extension Reaction Using 3’-O-ROX-SS-dATP for 5, 10, and 30 Cycles 
The extension reaction was carried out using 200 pmol of reversible terminator 3’-O-SS-Rox-
dATP, 2 units of TherminatorTM IX DNA Polymerase (NEB), 20 pmol of DNA primer (E8AA, 
M.W. 6084, see Table 2-1), 100 pmol of DNA template (Exon8, see Table 2-1) in a 20 μl buffer 
containing 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton X-100, 
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pH 8.8 @ 25OC, and 2 mM MnCl2. The reactions were conducted in an ABI GeneAmp PCR 
System 9700 with initial incubation at 65 OC for 30 second, followed by 5, 10, or 30 cycles of 65 
OC /30 sec, 45 OC /30 sec, 65 OC /30 sec. The reaction mixtures were desalted using Oligo Clean 
& ConcentratorTM (ZYMO Research) and analyzed by MALDI-TOF MS (ABI Voyager DE).  
   
3.2.2. Incorporation Comparison of 3’-O-Fluorescent/Anchor-SS-dNTPs and 3’-O-
Fluorescent/Anchor-PEG4-SS-dNTPs  
 
To compare the incorporation time for complete incorporation of the 3’-O-modified nucleotide 
with a PEG linker relative to one without a PEG linker, the synthesized dATP, dGTP, and dTTP 
analogues were examined. Reaction was carried out in solution with equimolar amounts of 3’-O-
modified nucleotide with a PEG linker and one without a PEG linker, TherminatorTM IX DNA 
polymerase, and cofactor ions for 5 PCR cycles. The MALDI-TOF MS analysis of equimolar 
amounts 3’-O-ROX-SS-dATP and 3’-O-ROX-PEG4-SS-dATP (Exp1, Figure 3-2) show that 
around 50% of the primers were extended to form the extension products, of which about 80% of 
the primers were extended by 3’-O-ROX-PEG4-SS-dATP to form extension product 2; the rest of 
the extended primers were extended by 3’-O-ROX-SS-dATP to form extension product 1. Similar, 
the MALDI-TOF MS analysis of equimolar amounts 3’-O-TCO-SS-dGTP and 3’-O-TCO-PEG4-
SS-dGTP (Exp 2, Figure 3-3) show that around 40% of the primers were extended to form 
extension products, of which about 75% of the primers were extended by 3’-O-TCO-PEG4-SS-
dGTP to form extension product 2; the remainder were extended by 3’-O-TCO-SS-dGTP to form 
extension product 1. Moreover, the MALDI-TOF MS analysis of equimolar amounts 3’-O-
BodipyFL-SS-dTTP and 3’-O-BodipyFL-PEG4-SS-dTTP (Exp3, Figure 3-4) show that around 
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90% of the primers were extended to form extension products, of which about 55% of the primers 
were extended by 3’-O-BodipyFL-PEG4-SS-dTTP to form extension product 2; with the rest 
extended by 3’-O-BodipyFL-SS-dTTP to form extension product 1. 
 
The results indicate that the incorporation efficiency of a 3’-O-modified nucleotide with a PEG 
linker is higher than one without a PEG linker in a competitive reaction, especially for the dATP 
and dGTP derivatives. We believe that the PEG linker could extend a bulky fluorescent group 
away from the reaction sites of the polymerase ternary complex, resulting in better incorporation 
efficiency. A similar result demonstrating that the longer the linker at the 3’ position of the 
modified nucleotide, the less disturbance to the incorporation reaction has been reported by Kim 





Figure 3-2. MALDI-TOF MS result for extension reaction with a mixture of 3’-O-ROX-SS-dATP 
and 3'-O-ROX-PEG4-SS-dATP at a 1:1 ratio (Exp1). The height of the peak for extension product 
2 with 3'-O-ROX-PEG4-SS-dATP (M.W. 7314) is much greater than that of the peak for extension 





Figure 3-3. MALDI-TOF MS result for extension reaction with a mixture of 3’-O-TCO-SS-dGTP 
and 3'-O-TCO-PEG4-SS-dGTP at a 1:1 ratio (Exp2). The height of the peak for extension product 
2 with 3'-O-TCO-PEG4-SS-dGTP (M.W. 7011) is much greater than that of the peak for extension 




Figure 3-4. MALDI-TOF MS result for extension reaction with a mixture of 3’-O-BodipyFL-SS-
dTTP and 3'-O-BodipyFL-PEG4-SS-dTTP at a 1:1 ratio (Exp3). The height of the peak for 
extension product 2 with 3'-O-BodipyFL-PEG4-SS-dTTP (M.W. 6140) is greater than that of the 





Polymerase Extension Reaction Using a Mixture of 3’-O-SS-Cleavable Fluorescent/Anchor 
Modified NRTs with and without a PEG Linker at a Ratio of 1:1 (5 cycles) 
The extension reaction was carried out using 100 pmol each of 3’-O-Fluorescent/Anchor-SS-
dNTPs reversible terminator without and with PEG linker, 2 units of TherminatorTM IX DNA 
Polymerase (NEB), 20 pmol of corresponding DNA primer (E8AA, E8CC, E8TT, or E7GG), 100 
pmol of corresponding DNA template (Exon8 or Exon7), in a 20 μl buffer containing 20 mM Tris-
HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton X-100, pH 8.8 @ 25OC, and 2 
mM MnCl2. The detailed combinations of compounds for each reaction have been shown in Table 
3-1. The reaction was conducted in an ABI GeneAmp PCR System 9700 with initial incubation at 
65 OC for 30 second, followed by 5 cycles of 65 OC /30 sec, 45 OC /30 sec, 65 OC /30 sec. The 
reaction mixtures were desalted using Oligo Clean & ConcentratorTM (ZYMO Research) and 
analyzed by MALDI-TOF MS (ABI Voyager DE).  
 
Table 3-1. The combination of 3’-O-SS-cleavable fluorescent/anchor modified NRTs, DNA 
primers and templates used in each comparison incorporation reaction. 
 NRT without PEG NRT with PEG Primer* Template* 
Exp1 3’-O-ROX-SS-dATP 3’-O-ROX-PEG4-SS-dATP E8AA Exon8 
Exp2 3’-O-TCO-SS-dGTP 3’-O-TCO-PEG4-SS-dGTP E7GG Exon7 
Exp3 3’-O-BodipyFL-SS-dTTP 3’-O-BodipyFL-PEG4-SS-dTTP E8TT Exon8 






3.3. Incorporation Comparison of 3’-O-SS-Cleavable Fluorescent/Anchor Modified 
NRTs and 3’-O-tert-Butyl-SS-dNTPs 
 
In developing the novel SBS approach with 3’-O-SS-cleavable fluorescent/anchor modified 
NRTs, 3’-O-SS modified NRTs without a reporter (3’-O-tert-Butyl-SS-dNTPs) has been 
introduced to the sequencing procedure in a chase step (to further fill up the occupancy of the 
growing DNA strands that were not extended with 3’-O-SS-cleavable fluorescent/anchor modified 
NRTs to assure the growing DNA strands temporarily terminated at the same length). Instead of 
two consecutive incorporation steps (first extension with 3’-O-SS-cleavable fluorescent/anchor 
modified NRTs; then chase with 3’-O-tert-Butyl-SS-dNTPs), 3’-O-SS-cleavable 
fluorescent/anchor modified NRTs and 3’-O-tert-Butyl-SS-dNTPs may be added simultaneously 
in the extension step to reduce usages of 3’-O-SS-cleavable fluorescent/anchor modified NRTs, 
3’-O-tert-Butyl-SS-dNTPs and polymerase, as well as process time in each cycle. Also, once the 
ideal combination of 3’-O-SS-cleavable fluorescent/anchor modified NRTs and 3’-O-tert-Butyl-
SS-dNTPs has been found, the further chase step may be removed in the SBS protocol. Therefore, 
another factor of interest is the differentiation of reaction rate between 3’-O-SS-cleavable 
fluorescent/anchor modified NRTs and 3’-O-tert-Butyl-SS-dNTPs. Based on the previous result, 
indicating that the rate of incorporation of the 3’-O-modified NRT with a PEG linker is much fast 
than that without a PEG linker, the 3’-O-Fluorescent/Anchor-PEG4-SS-dNTPs were used to 
compare with 3’-O-tert-Butyl-SS-dNTPs in the incorporation reaction. The synthetic procedure 





Here, the incorporation efficiencies of 3’-O-tert-Butyl-SS-dNTPs have been individually 
examined in a short reaction time (5 PCR cycles) as a reference. The reaction was carried out in 
solution with each 3’-O-tert-Butyl-SS-dNTP, TherminatorTM IX DNA polymerase, and cofactor 
ions. The MALDI-TOF MS analysis confirmed that TherminatorTM IX DNA polymerase with 
added Mn2+ results in excellent incorporation efficiency for 3’-O-tert-Buyl-SS-dATP, 3’-O-tBuyl-
SS-dTTP,  3’-O-tBuyl-SS-dGTP, and 3’-O-tBuyl-SS-dCTP as evidenced by the single observed 
peak in the mass spectrum (MS) of 6520 Da (6531 Da expected) (see Figure 3-5), of 5602 Da 
(5604 Da expected) (see Figure 3-6), of 6605 Da (6597 Da expected) (see Figure 3-7), and of 
5573 Da (5570 Da expected) (see Figure 3-8), respectively. 
 
Scheme 3-1. Synthesis of 3’-O-tert-butyldithiomethyl-dNTPs (3’-O-tert-Butyl-SS-dNTPs). i. 
DMSO, AcOH, Ac2O, r.t., 18 hrs; ii. SO2Cl2, DCM, r.t., 1 hr; iii. Potassium thiotosylate, DCM, 
r.t., 1 hr; iv. Tert-butyl mercaptan, DCM, r.t., 30 mins; v. TBAF, THF, r.t., 4 hrs; vi. TBAP, SalPCl, 





Figure 3-5. MALDI-TOF MS result for extension reaction using 3’-O-tert-Butyl-SS-dATP 
shows extension was complete by 5 cycles of extension. 
 
 
Figure 3-6. MALDI-TOF MS result for extension reaction using 3’-O-tert-Butyl-SS-dTTP 





Figure 3-7. MALDI-TOF MS result for extension reaction using 3’-O-tert-Butyl-SS-dGTP shows 
extension was complete by 5 cycles of extension. 
 
 
Figure 3-8. MALDI-TOF MS result for extension reaction using 3’-O-tert-Butyl-SS-dCTP shows 







General Approach for Polymerase Extension Reaction Using 3’-O-tert-Butyl-SS-dNTP (5 
cycles) 
The extension reaction was individually carried out using 20 pmol of the template (Exon8 or Exon7,  
see Table 2-1), 60 pmol primer (E8AA, E8CC, E8TT, or E7GG, see Table 2-1), 200 pmol of 
reversible terminator 3’-O-tert-Butyl-SS-dNTP, 2 units of TherminatorTM IX DNA Polymerase 
(NEB), in 20 l 1X ThermoPolMT Reaction Buffer containing 20 mM Tris-HCl, 10 mM 
(NH4)2SO4, 10 mM KCl, 2 mM MgSO4, and 0.1% Triton® X-100, pH 8.8 @ 25OC. The reactions 
were conducted in an ABI GeneAmp PCR System 9700 with initial incubation at 65 OC for 30 
second, followed by 5 cycles of 65 OC /30 sec, 45 OC /30 sec, 65 OC /30 sec. The reaction mixtures 
were desalted using Oligo Clean & ConcentratorTM (ZYMO Research) and analyzed by MALDI-
TOF MS (ABI Voyager DE). 
 
3.3.1. Incorporation Comparison of 3’-O-ROX-PEG4-SS-dATP and 3’-O-tert-Butyl-
SS-dATP  
 
With the incorporation efficiency of 3’-O-tert-Butyl-SS-dATP established, we proceeded to 
conduct a competition experiment with the above NRT and 3’-O-ROX-PEG4-SS-dATP.  
Reactions were carried out in solution with 3’-O-tert-Butyl-SS-dATP, 3’-O-ROX-PEG4-SS-dATP, 
TherminatorTM IX DNA polymerase, and cofactor ions. Three reaction batches were set up with 
different ratios of the two 3’-O-modified nucleotides (3’-O-tert-Butyl-SS-dATP: 3’-O-ROX-
PEG4-SS-dATP = 1:20, 1:10, and 1:4) with short reaction time (5 cycles). MALDI-TOF MS 
analysis was used to measure the relative production of extension product 1 (M.W. 6531 Da), in 
which the primer was extended by 3’-O-tert-Butyl-SS-dATP and extension product 2 (M.W. 7312 
Da), in which the primer was extended by 3’-O-ROX-PEG4-SS-dATP.  With low amounts of 3’-
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O-tert-Butyl-SS-dATP, the incorporation reactions produce predominantly extension product 2. 
With a 1:20 ratio of 3’-O-tert-Butyl-SS-dATP: 3’-O-ROX-PEG4-SS-dATP, around 50% of the 
primers were extended to form extension products, in which 90% are extension product 2 and the 
rest are extension product 1 (see Figure 3-9(a)).  With a 1:10 ratio of 3’-O-tert-Butyl-SS-dATP: 
3’-O-ROX-PEG4-SS-dATP, around 80% of the primers were extended to form extension products, 
in which 75% are extension product 2 and the rest are extension product 1 (see Figure 3-9(b)). 
Finally, at a 1:4 ration of 3’-O-tert-Butyl-SS-dATP: 3’-O-ROX-PEG4-SS-dATP, all primers were 
extended to from extension products, in which the amount of extension product 1 became dominant, 
representing 85% of the extension products (see Figure 3-9(c)). The result indicates that the 
incorporation efficiency of 3’-O-tert-Butyl-SS-dATP is much higher than that of 3’-O-ROX-
PEG4-SS-dATP when they are in competition. Moreover, the analysis of MS peak heights of the 
extension products of the two 3’-O-modified nucleotides indicates that if both 3’-O-tert-Butyl-SS-
dATP and 3’-O-ROX-PEG4-SS-dATP are applied cooperatively in the SBS reaction, their ratio 
could be used to control the amount of the fluorescent modified extension product in a given cycle 





Figure 3-9. MALDI-TOF MS results for extension reactions using a mixture of 3’-O-tert-Butyl-
SS-dATP and 3’-O-ROX-PEG4-SS-dATP at ratios of 1:20 (a), 1:10 (b), and 1:4 (c). The extension 
reaction was carried out in solution, producing extension products with 3’-O-tert-Butyl-SS-dATP 
(Extension Product 1, M.W. 6531) and 3’-O-ROX-PEG4-SS-dATP (Extension Product 2, M.W. 
7312). At the lowest percent of 3’-O-tert-Butyl-SS-dATP, extension product 2 is the dominant 
product, while increasing the ratio to 1:4 (c) results in extension product 1 becoming the dominant 
product. The MS result indicates that 3’-O-tert-Butyl-SS-dATP can be incorporated with a higher 






3.3.2. Incorporation Comparison of 3’-O-BodipyFL-PEG4-SS-dTTP and 3’-O-tert-
Butyl-SS-dTTP  
 
Similarly, the high incorporation efficiency of 3’-O-tert-Butyl-SS-dTTP has been validated. 
We proceeded to conduct a competition experiment with the above NRT and 3’-O-BodipyFL-
PEG4-SS-dTTP. Reactions were carried out in solution with 3’-O-tert-Butyl-SS-dTTP, 3’-O-
BodipyFL-PEG4-SS-dTTP, TherminatorTM IX DNA polymerase, and cofactor ions. Three reaction 
batches were set up with different ratios of the two 3’-O-modified nucleotides (3’-O-tert-Butyl-
SS-dTTP: 3’-O-BodipyFL-PEG4-SS-dTTP = 1:20, 1:10, and 1:4) with short reaction time (5 
cycles). MALDI-TOF MS analysis was used to compare the relative amount of extension product 
1 (M.W. 5604 Da), in which the primer was extended by 3’-O-tert-Butyl-SS-dTTP and extension 
product 2 (M.W. 6140 Da), in which the primer was extended by 3’-O-BodipyFL-PEG4-SS-dTTP.  
Compared with the same series of experiments for the dATP analogues, in this case the primer was 
completely extended to from the extension products, indicating the incorporation efficiencies of 
both examined dTTP analogues are higher than the dATP analogues. Similarly, with low amounts 
of 3’-O-tert-Butyl-SS-dTTP, the incorporation reactions produce mainly extension product 2. With 
a 1:20 ratio of 3’-O-tert-Butyl-SS-dTTP: 3’-O-BodipyFL-PEG4-SS-dTTP, nearly all of the 
primers were extended to form extension product 2 (see Figure 3-10(a)).  With a 1:10 ratio of 3’-
O-tert-Butyl-SS-dTTP: 3’-O-BodipyFL-PEG4-SS-dTTP, around 80% of the primers were 
extended to form extension product 2 and the rest were extended to form extension product 1 (see 
Figure 3-10(b)). Increasing to a 1:4 ratio of 3’-O-tert-Butyl-SS-dTTP: 3’-O-BodipyFL-PEG4-SS-
dTTP, extension product 1 became the dominant product, at 70% of the total (see Figure 3-10(c)). 
The result indicates that the incorporation efficiency of 3’-O-tert-Butyl-SS-dTTP is much higher 
that of than 3’-O-BodipyFL-PEG4-SS-dTTP when they are in competition. Moreover, analysis of 
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MS peak heights of the extension products with the two 3’-O-modified nucleotides indicates that 
if both 3’-O-tert-Butyl-SS-dTTP and 3’-O-BodipyFL-PEG4-SS-dTTP are applied cooperatively in 
the SBS reaction, their ratio could be used to control the amount of the fluorescent modified 
extension product in a given cycle of extension.  
 
Figure 3-10. MALDI-TOF MS results for extension reactions using a mixture of 3’-O-tert-Butyl-
SS-dTTP and 3’-O-BodipyFL-PEG4-SS-dTTP at 1:20 (a), 1:10 (b), and 1:4 (c) ratios. The 
extension reaction was carried out in solution, producing extension products with 3’-O-tert-Butyl-
SS-dTTP (Extension Product 1, M.W. 5604) and 3’-O-BodipyFL-PEG4-SS-dTTP (Extension 
Product 2, M.W. 6140). With low amounts of 3’-O-tert-Butyl-SS-dTTP, extension product 2 is the 
dominant product, while at a ratio of 1:4 (c), extension product 1 becomes dominant. The MS 




3.3.3. Incorporation Comparison of 3’-O-TCO-PEG4-SS-dGTP and 3’-O-tert-Butyl-
SS-dGTP  
 
With the high incorporation efficiency of 3’-O-tert-Butyl-SS-dGTP established, we similarly 
proceeded to conduct a competition experiment with the above NRT and 3’-O-TCO-PEG4-SS-
dGTP. Reactions were carried out in solution with 3’-O-tert-Butyl-SS-dGTP, 3’-O-TCO-PEG4-
SS-dGTP, TherminatorTM IX DNA polymerase, and cofactor ions. Three reaction batches were set 
up with different ratios of the two 3’-O-modified nucleotides (3’-O-tert-Butyl-SS-dGTP: 3’-O-
TCO-PEG4-SS-dGTP = 1:10, 1:4, and 1:2) with short reaction time (5 cycles). MALDI-TOF MS 
analysis was used to compare the relative amount of extension product 1 (M.W. 6597 Da), in which 
the primer was extended by 3’-O-tert-Butyl-SS-dGTP and extension product 2 (M.W. 7011 Da), 
in which the primer was extended by 3’-O-TCO-PEG4-SS-dGTP.  Compared with the same series 
of experiments for the dATP and dTTP analogues, with low amounts of 3’-O-tert-Butyl-SS-dGTP, 
the incorporation reactions produce higher proportions of extension product 2. With a 1:10 ratio 
of 3’-O-tert-Butyl-SS-dGTP: 3’-O-TCO-PEG4-SS-dGTP, around 55% of the primers were 
extended to form extension products, in which 90% are extension product 2 and the rest are 
extension product 1 (see Figure 3-11(a)).  With a 1:4 ratio of 3’-O-tert-Butyl-SS-dGTP: 3’-O-
TCO-PEG4-SS-dGTP, around 70% of the primers were extended to form extension products, in 
which 65% are extension product 2 and the rest are extension product 1 (see Figure 3-11(b)). 
Increasing to a 1:2 ratio of 3’-O-tert-Butyl-SS-dGTP: 3’-O-TCO-PEG4-SS-dGTP, around 85% of 
the primers were extended to form extension products, in which 35% are extension product 2 and 
the rest are extension product 1 (see Figure 3-11(c)). The result indicates that the incorporation 
efficiency of 3’-O-tert-Butyl-SS-dGTP is much higher than 3’-O-TCO-PEG4-SS-dGTP when they 
are in competition. Moreover, analysis of MS intensities of the extension products with the two 
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3’-O-modified nucleotides indicates that if both 3’-O-tert-Butyl-SS-dGTP and 3’-O-TCO-PEG4-
SS-dGTP are applied cooperatively in the SBS reaction, their ratio could be used to control the 
amount of the fluorescent modified extension product in a given cycle of extension.  
 
Figure 3-11. MALDI-TOF MS results for extension reactions using a mixture of 3’-O-tert-Butyl-
SS-dGTP and 3’-O-TCO-PEG4-SS-dGTP at 1:10 (a), 1:4 (b), and 1:2 (c) ratios. The extension 
reaction was carried out in solution, producing extension products with 3’-O-tert-Butyl-SS-dGTP 
(Extension Product 1, M.W. 6597) and 3’-O-TCO-PEG4-SS-dGTP (Extension Product 2, M.W. 
7011). With low amounts of 3’-O-tert-Butyl-SS-dGTP, extension product 2 is the dominant 
product, while at a ratio of 1:4 (c), extension product 1 becomes dominant. The MS result indicates 




3.3.4. Incorporation Comparison of 3’-O-Biotin-SS-dCTP and 3’-O-tert-Butyl-SS-
dCTP  
 
Finally, with the high incorporation efficiency of 3’-O-tert-Butyl-SS-dCTP established, we 
proceeded to conduct a competition experiment with the above NRT and 3’-O-Biotin-SS-dCTP. 
Reactions were carried out in solution with 3’-O-tert-Butyl-SS-dCTP, 3’-O-Biotin-SS-dCTP, 
TherminatorTM IX DNA polymerase, and cofactor ions. Three reaction batches were set up with 
different ratios of the two 3’-O-modified nucleotides (3’-O-tert-Butyl-SS-dCTP: 3’-O-Biotin-SS-
dCTP = 1:20, 1:10, and 1:4) with short reaction time (5 cycles). MALDI-TOF MS analysis was 
used to compare the relative amount of extension product 1 (M.W. 5570 Da), in which the primer 
was extended by 3’-O-tert-Butyl-SS-dCTP and extension product 2 (M.W. 5811 Da), in which the 
primer was extended by 3’-O-Biotin-SS-dCTP.  With a 1:20 ratio of 3’-O-tert-Butyl-SS-dCTP: 3’-
O-Biotin-SS-dCTP, around 50% of the primers were extended to form mainly extension product 
2 (see Figure 3-12(a)).  With a 1:10 ratio of 3’-O-tert-Butyl-SS-dCTP: 3’-O-Biotin-SS-dCTP, 
around 60% of the primers were extended to form extension products, in which 45% are extension 
product 2 and the rest are extension product 1 (see Figure 3-12(b)). Increasing to a 1:4 ratio of 3’-
O-tert-Butyl-SS-dCTP: 3’-O-Biotin-SS-dCTP, around 75% of the primers were extended to form 
extension products, in which 20% are extension product 2 and the rest are extension product 1 (see 
Figure 3-12(c)). The result indicates that the incorporation efficiency of 3’-O-tert-Butyl-SS-dCTP 
is much higher than 3’-O-Biotin-SS-dCTP when they are in competition. Moreover, analysis of 
MS intensities of the extension products with the two 3’-O-modified nucleotides indicates that if 
both 3’-O-tert-Butyl-SS-dCTP and 3’-O-Biotin-SS-dCTP are applied cooperatively in the SBS 
reaction, their ratio could be used to control the amount of the fluorescent modified extension 





Figure 3-12. MALDI-TOF MS results for extension reactions using a mixture of 3’-O-tert-Butyl-
SS-dCTP and 3’-O-Biotin-SS-dCTP at 1:20 (a), 1:10 (b), and 1:4 (c) ratios. The extension reaction 
was carried out in solution, producing extension product with 3’-O-tert-Butyl-SS-dCTP 
(Extension Product 1, M.W. 5570) and 3’-O-Biotin-SS-dCTP (Extension Product 2, M.W. 5811). 
With low amounts of 3’-O-tert-Butyl-SS-dCTP, extension product 2 is the dominant product, 
while at a ratio of 1:4 (c), extension product 1 becomes dominant. The MS result indicates that 3’-






Polymerase Extension Reactions Using 3’-O-SS-Cleavable Fluorescent/Anchor Modified NRTs 
and 3’-O-tert-Butyl-SS-dNTPs at Various Concentration Ratios 
The extension reaction was carried out using various amounts of 3’-O-tert-Butyl-SS-dNTP, 200 
pmol of 3’-O-SS-cleavable fluorescent/anchor modified NRT, 2 units of TherminatorTM IX DNA 
Polymerase (NEB), 20 pmol of DNA primer (E8AA, E8CC, E8TT, or E7GG), 100 pmol of DNA 
template (Exon8 or Exon7) in a 20 μl buffer containing 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 
mM KCl, 2 mM MgSO4, 0.1% Triton X-100, pH 8.8 @ 25OC, and 2 mM MnCl2. The detailed 
combinations of compounds for each reaction have been shown in Table 3-2. The reaction was 
conducted in an ABI GeneAmp PCR System 9700 with initial incubation at 65 OC for 30 second, 
followed by 5 cycles of 65 OC /30 sec, 45 OC /30 sec, 65 OC /30 sec. The reaction mixtures were 
desalted using Oligo Clean & ConcentratorTM (ZYMO Research) and analyzed by MALDI-TOF 











Table 3-2. The combination of 3’-O-SS-cleavable fluorescent/anchor modified NRTs, 3’-O-tert-







Exp1 3’-O-tert-Butyl-SS-dATP 3’-O-ROX-PEG4-SS-dATP   
(a) 5 pmol 100 pmol E8AA Exon8 
(b) 10 pmol 100 pmol E8AA Exon8 
(c) 25 pmol 100 pmol E8AA Exon8 
Exp2 3’-O-tert-Butyl-SS-dTTP 3’-O-BodipyFL-PEG4-SS-dTTP   
(a) 5 pmol 100 pmol E8TT Exon8 
(b) 10 pmol 100 pmol E8TT Exon8 
(c) 25 pmol 100 pmol E8TT Exon8 
Exp3 3’-O-tert-Butyl-SS-dGTP 3’-O-TCO-PEG4-SS-dGTP   
(a) 10 pmol 100 pmol E7GG Exon7 
(b) 25 pmol 100 pmol E7GG Exon7 
(c) 50 pmol 100 pmol E7GG Exon7 
Exp4 3’-O-tert-Butyl-SS-dCTP 3’-O-Biotin-SS-dCTP   
(a) 10 pmol 200 pmol E8CC Exon8 
(b) 20 pmol 200 pmol E8CC Exon8 
(c) 50 pmol 200 pmol E8CC Exon8 














3.4. Demonstration of Incorporation of 3’-O-SS-Cleavable Fluorescent/Anchor 
Modified NRTs to Obtain a Continuous Four Base Sequence in Solution 
 
To further develop scarless SBS using the novel designed 3’-O-SS-cleavable 
fluorescent/anchor modified NRTs, a combination of two 3’-O-SS-cleavable fluorescent and two 
3’-O-SS-cleavable anchor nucleotide analogues has been performed to demonstrate SBS for a 
successive four base sequence. Reactions were carried out in solution with 3’-O-ROX-PEG4-SS-
dATP, 3’-O-BodipyFL-SS-dTTP, 3’-O-Biotin-SS-dCTP, and 3’-O-TCO-SS-dGTP, 
TherminatorTM IX DNA polymerase, and cofactor ions. The four nucleotides were prepared as a 
mixture for all four successive incorporation reactions. The experiments were done using a DNA 
sequencing by synthesis procedure. In each synthesis cycle, one base was extended to produce the 
extension product, which was isolated and characterized. Then, after treating with THP to 
regenerate the 3’-OH of the growing strand, the resulting product was ready for the next SBS cycle. 
As shown in the scheme at the left in Figure 3-13, 4 cycles of extension (a, c, e, g) and cleavage 
(b, d, f, h) were conducted to add A, C, G, and T to the 3’ end of these primers. The results of 
MALDI-TOF MS analysis confirmed that the correct nucleotides were added and then converted 
to natural nucleotides containing a free 3’-OH group in each cycle. Addition of the nucleotide 
mixture to the 13-mer primer annealed to a DNA template resulted in complete incorporation of 
3’-O-ROX-PEG4-SS-dATP into the primer as evidenced by the single observed peak in the mass 
spectrum of 5188 Da (5188 Da expected) (see Figure 3-13(a)). After treatment with THP to cleave 
the 3’-O-SS-PEG4-ROX group, a single MS peak was observed at 4264 Da (4272 Da expected) 
(see Figure 3-13(b)). Extension of the 14-mer primer in the second cycle revealed incorporation 
of 3’-O-Biotin-SS-dCTP into the growing primer strand as evidenced by the single observed MS 
peak of 4941 Da (4939 Da expected) (see Figure 3-13(c)). After treatment with THP to cleave the 
108 
 
3’-O-SS-Biotin, a single cleavage peak was formed at 4565 Da (4561 Da expected) (see Figure 3-
13(d)). In the third cycle, incorporation of 3’-O-TCO-SS-dGTP generated a MS peak of 5184 Da 
(5194 Da expected) (see Figure 3-13(e)) and complete cleavage of the anchor and restoration of 
the 3’-OH group resulted a MS peak at 4894 Da (4890 Da expected) (see Figure 3-13(f)). Finally, 
in the fourth cycle, the extended 16mer DNA strand was used as a primer for 3’-O-BodipyFL-SS-
dTTP incorporation. The MS results demonstrated a single peak with molecular weight of 5621 
Da (5620 Da expected) (see Figure 3-13(g)) for 3’-O-BodipyFL-SS-dTTP incorporation and 5197 
Da (5195 Da expected) (see Figure 3-13(h)) after cleavage. The successive extensions of the 
synthesized primer and the growing strands using the mixture of novel synthesized 3’-O-
Fluorescent-(PEG4)-SS-dNTPs and 3’-O-Anchor-SS-dNTPs in the SBS cycles were a successful 
proof of principle of the scarless SBS protocol, supporting the development of the novel designed 





Figure 3-13. Continuous SBS in solution using 3'-O-ROX-PEG4-SS-dATP, 3'-O-BodipyFL-SS-
dTTP, 3'-O-Biotin-SS-dCTP and 3'-O-TCO-SS-dGTP. 
 
Polymerase Extension Reactions Using 3’-O-SS-Cleavable Fluorescent/Anchor Modified NRTs 
for Successive Four Base Sequencing 
The extension reactions were carried out using 3'-O-ROX-PEG4-SS-dATP, 3'-O-BodipyFL-SS-
dTTP, 3'-O-Biotin-SS-dCTP and 3'-O-TCO-SS-dGTP. Replicate reactions consisted of 150 pmol 
of 3’-O-SS-cleavable fluorescent/anchor modified NRTs mixture, 100 pmol of DNA primer or 
base-extended primers (13-16mer), 2 units of TherminatorTM IX DNA Polymerase (NEB), 20 pmol 
of DNA template in a 20 μl buffer containing 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 
2 mM MgSO4, 0.1% Triton X-100, pH 8.8 @ 25OC, and 2 mM MnCl2. The reaction was conducted 
in an ABI GeneAmp PCR System 9700 with initial incubation at 65 OC for 30 second, followed 
by 38 cycles of 65 OC /30 sec, 45 OC /30 sec, 65 OC /30 sec. Reactions from all the replicate tubes 
were pooled and HPLC was used to remove unused nucleotide analogues and salt and obtain pure 
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incorporation products as verified by MALDI-TOF MS (ABI Voyager DE). Cleavage with 100 
pmol THP for 3 minutes at 65 OC led to recovery of the 3’-OH of extended products. The samples 
were treated with Oligo Clean & ConcentratorTM (ZYMO Research) to remove salt and cleaved 
groups and analyzed by MALDI-TOF MS (ABI Voyager DE); the result is shown in Figure 3-13. 
The 13-mer shown below was used in the initial reaction. In subsequent cycles, primers extended 
at the 3’ end with the base from the previous cycle were used. 
51-mer template: 
5’-TACATCAACTACCCGGAGGCCAAGTACGGCGGGTACGTCCTTGACAATGTG-3’ 
The underlined sequence is a complementary sequence of each corresponding primer sequence. 
13-mer primer: 
5’-CACATTGTCAAGG-3’ (M.W. 3959 Da) 
After each incorporation, the expected size (molecular weight) of the products are 5188 Da, 4939 

















3.5. SBS Using 3’-O-SS-Cleavable Fluorescent/Anchor Modified NRTs on-Chip 
Immobilized DNA Primer-Loop Template 
 
To demonstrate the scarless SBS on a chip by using the 3’-O-SS-cleavable fluorescent/anchor 
modified NRTs as substrates, two 3’-O-SS-clavable fluorescent and two 3’-O-SS-cleavable anchor 
nucleotide analogues have been used to demonstrate the sequencing procedure on the chip. The 
individual single base extensions using 3'-O-ROX-PEG4-SS-dATP and 3'-O-BodipyFL-PEG4-SS-
dTTP, as well as 3'-O-TCO-PEG4-SS-dGTP, and 3'-O-Biotin-SS-dCTP with their corresponding 
binding molecules, tetrazine-PEG4-TAMRA and streptavidin-Cy5, respectively, were performed 
and the fluorescent emission of extended products imaged using a scanner (ScanArray® Express, 
PerkinElmerTM), as shown in Figure 3-14. 
 
Figure 3-14. Fluorescence emission images of extended products using a scanner (ScanArray® 
Express, PerkinElmerTM). Scanner 488 nm channel (ex = 488 nm;, em = 522 nm) and 594 nm 
channel (ex = 594 nm;, em = 614 nm) were used to detect incorporated products for 3'-O-
BodipyFL-PEG4-SS-dTTP (a) and 3'-O-ROX-PEG4-SS-dATP (b); 543 nm (ex = 546 nm; em = 
570 nm) and 633 nm (ex = 633 nm; em = 670 nm) were used to detect incorporated products for 
3'-O-TCO-PEG4-SS-dGTP, after labeling with TAMRA-PEG4-tetrazine (c) and 3'-O-Biotin-SS-
dCTP, after labeling with Cy5-streptavidin (d) on an immobilized DNA primer-loop template. 
Bright spots represent the detected fluorescent emission. Fluorescence emission images of 
cleavage products also presented in (e), (f), (g), and (h) at the corresponding scanner channels for 
each case.  
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Construction of a Chip with Immobilized Self-priming DNA 
Self-priming DNA templates were immobilized on a glass slide as illustrated in Figure 3-13. 
5’-amino modified self-priming template DNA (the detailed sequence is shown in SBS protocols) 
was dissolved in 50 mM sodium phosphate buffer (pH 9.0), at a concentration of 30 μM and spotted 
on NHS ester-5 activated CodeLink slides (Surmodics Inc., MN) using a SpotArray 72 microarray-
printing robot (PerkinElmer, MA). The slides were incubated in a humid chamber containing a 
solution of saturated sodium chloride to immobilize the DNA at 37°C overnight, followed by 
incubation in a solution of 50 mM 3-amino-1-propanol in 100 mM tris-HCl buffer, pH 9.0 for 2 
hours at room temperature to quench unreacted NHS ester groups. The slide was then quickly 
rinsed in water, dried under compressed air and stored in a desiccator in the dark for further use. 
 
A HybriWell Sealing System (Cat. 611104, Grace Bio-Labs, OR) was mounted on the glass 
slide with surface-immobilized self-priming DNA as illustrated in Figure 3-16. This sealing 
system provides strictly uniform and identical reaction conditions among spot arrays. Moreover, 
the boundary of each spot does not suffer from erosion occurring unavoidably with repeated 





Figure 3-15. Construction of a slide with immobilized self-priming DNA. Self-priming template 
was selected to minimize the dissociation of the primers from the template during the numerous 
incubation and washing steps. 
 
                                              
Figure 3-16. Construction of a lab scale SBS system. A HybriWell Sealing System was mounted 




Fluorescent Detection Using 4 Laser Channel Scanner 
Fluorescent reporters have been attached to the synthesized nucleotides used in the SBS 
reactions. As designed, the fluorescent dyes are either directly attached to the 3’-O position or 
bound to the anchors which are attached at the 3’-O position of nucleotides. Four unique 
fluorophores have been selected as the reporters, each having a distinguishable fluorescence 
emission (see Figure 3-17). For detection of fluorescent reporters, a scanner (ScanArray® Express, 
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PerkinElmerTM) with four laser channels, 488 nm (the excitation wavelength, ex = 488 nm; the 
emission filter wavelength, em = 522 nm) for BodipyFL; 543 nm (ex = 546 nm; em = 570 nm) 
for TAMRA; 594 nm (ex = 594 nm; em = 614 nm) for ROX; 633 nm (ex = 633 nm; em = 670 
nm) for Cy5, has been used to produce the emission signals. Importantly, there is minimal overlap 
between the emission of one dye and the absorption of the next dye, which maintains low 




Figure 3-17. The excitation and emission spectra as well as molecular structures of the four 
fluorescent reporters used in this study. 
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3.5.1. SBS Using Two 3’-O-SS-Cleavable Fluorescent Modified NRTs on Chip 
Immobilized DNA Primer-Loop Templates 
 
Two 3’-O-SS-cleavable fluorescent modified NRTs have first been used to examine the 
sequencing procedure. An experiment to obtain the successive sequence was performed by 
addition of 3’-O-Fluorescent-PEG4-SS-dNTPs (3'-O-ROX-PEG4-SS-dATP and 3'-O-BodipyFL-
PEG4-SS-dTTP), 3’-O-tert-Butyl-SS-dNTPs (3’-O-tert-Butyl-SS-dATP, 3’-O-tert-Butyl-SS-
dTTP, 3’-O-tert-Butyl-SS-dCTP, and 3’-O-tert-Butyl-SS-dGTP), TherminatorTM IX DNA 
polymerase, and cofactor ions to the immobilized primed DNA template. The sequencing 
procedure (see Scheme 3-2) enables the incorporation of the complementary nucleotide analogue 
to the growing DNA strand to terminate DNA synthesis. After washing away unused nucleotides 
and DNA polymerase, the single base extended products were scanned to obtain the fluorescent 
images. In the following chase step, re-addition of the four 3’-O-tert-Butyl-SS-dNTPs and 
polymerase to the immobilized primed DNA template assures the incorporation of the 
complementary 3’-O-tert-Butyl-SS-dNTPs analogue to the growing DNA strands that were not 
extended with one of the dye labeled nucleotide analogues. Therefore, the growing DNA strands 
are terminated with one of four nucleotide analogues, dye labeled analogues or the same one of 
the two nucleotide analogues without dye. After washing away unused nucleotides and DNA 
polymerase, treatment with THP regenerated the 3’-OH on the growing DNA strand, and the 
resulting product was ready for the next cycle of SBS. After washing away cleavage byproducts, 
the cleavage products were scanned to confirm the background fluorescent images. Based on the 
previous incorporation results with 3’-O-Fluorescent-PEG4-SS-dNTPs and 3’-O-tert-Butyl-SS-
dNTPs in solution, a small amount of 3’-O-tert-Butyl-SS-dNTPs might assist to extend all the 
primers.  A small amount of all four 3’-O-tert-Butyl-SS-dNTPs (including 3’-O-tert-Butyl-SS-
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dATP and 3’-O-tert-Butyl-SS-dTTP), was therefore added. Also, although the amount of 3’-O-
tert-Butyl-SS-dATP and 3’-O-tert-Butyl-SS-dTTP would be expected to decrease the fluorescent 
intensities, the identification of 3'-O-ROX-PEG4-SS-dATP and 3'-O-BodipyFL-PEG4-SS-dTTP 
from fluorescent images is still feasible if a sufficient amount of 3’-O-Fluorescent-PEG4-SS-
dNTPs is added.  
SBS results for six cycles were obtained using the combination of 3’-O-Fluorescent-PEG4-SS-
dNTPs and 3’-O-tert-Butyl-SS-dNTPs (see Figure 3-18). The continuous sequence of the first 
four bases (fluorescent signal reading) were identified as A, T, T, and A. The fifth base sequence 
was silent because the unlabeled G was added to the growing strand. In the sixth cycle, a 
fluorescent signal was again obtained and identified as A. In each SBS cycle, the fluorescent signal 
for a correct read was high enough compared with other background signals, and maintained a 
similar intensity level after sequencing resumed. Although the signals obtained in reading the 
sequence were unambiguous, further optimization might further reduce the low background 
signals. The successful sequence reading over 6 continuous SBS cycles indicates that the novel 




Scheme 3-2. Scheme of scarless SBS using two 3’-O-Fluorescent-PEG4-SS-dNTPs (3'-O-ROX-
PEG4-SS-dATP and 3'-O-BodipyFL-PEG4-SS-dTTP) combined with four 3’-O-tert-Butyl-SS-
dNTPs (3’-O-tert-Butyl-SS-dATP, 3’-O-tert-Butyl-SS-dTTP, 3’-O-tert-Butyl-SS-dCTP, and 3’-
O-tert-Butyl-SS-dGTP) to perform DNA SBS. (Step 1) addition of  3’-O-Fluorescent-SS-dNTPs 
and 3’-O-tert-Butyl-SS-dNTPs to extend the growing DNA strand to terminate DNA synthesis; 
(Step 2) washing away unused nucleotides and DNA polymerase; (Step 3) imaging the 
immobilized DNA extension products to determine the incorporated nucleotides; (Step 4) chase 
with 3’-O-tert-Butyl-SS-dATP, 3’-O-tert-Butyl-SS-dTTP, 3’-O-tert-Butyl-SS-dCTP, and 3’-O-
tert-Butyl-SS-dGTP to extend the growing strands that were not extended with one of the dye 
labeled dNTPs in Step 1. (Step 5) washing away unused nucleotides and DNA polymerase; (Step 
6) cleavage of the SS linker with THP to regenerate the 3’-OH of the growing DNA strand; (Step 
7) washing away the cleaved moieties and reagents; (Step 8) imaging the immobilized DNA 




Figure 3-18. Six cycles of SBS obtained using 3'-O-ROX-PEG4-SS-dATP and 3'-O-BodipyFL-
PEG4-SS-dTTP.  The signals correctly identified the sequence 5’-ATTAXA-3’ (X is silent in the 
test). In each cycle, the fluorescent signals of extension were collected from the first imaging (step 
3) (E), and that of cleavage were collected from the second imaging (step 8) (C). 
 
Demonstration of SBS Using 3’-O-Fluorescent-PEG4-SS-dNTPs and 3’-O-tert-Butyl-SS-
dNTPs on an Immobilized DNA Primer-Loop Template  
Using the looped priming template shown at the top of Figure 3-18, in which the next six bases to 
be added are A, T, T, A, G, A, reactions were carried out as in the protocol for Scheme 3-2. 5’-
NH2-modified template was immobilized on NHS ester-modified slides from Surmodics. Each 
cycle was carried out as follows: (1) extension with 60 l of 0.4 M 3'-O-ROX-PEG4-SS-dATP, 
0.4 M 3'-O-BodipyFL-PEG4-SS-dTTP, 0.05 M 3’-O-tert-Butyl-SS-dATP, 0.05 M 3’-O-tert-
Butyl-SS-dTTP, 0.05 M 3’-O-tert-Butyl-SS-dCTP, 0.05 M 3’-O-tert-Butyl-SS-dGTP, 6 units 
of TherminatorTM IX DNA Polymerase (NEB), in 1X Thermo Pol buffer containing 20 mM Tris-
HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton X-100, pH 8.8 @ 25OC, and 2 
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mM MnCl2 for 10 minutes at 65 OC. (2) washing with water, 1X SPSC buffer, and water again. (3) 
scanning air dried slides at 488 nm (ex = 488 nm; em = 522 nm) and 594 nm (ex = 594 nm; em 
= 614 nm) (ScanArray® Express, PerkinElmerTM) to record fluorescence intensity of spots. (4) 
chase with 60 l of 4 M each of the four 3’-O-tert-Butyl-SS-dNTPs, 6 units of TherminatorTM IX 
DNA Polymerase (NEB), in 1X Thermo Pol buffer containing 20 mM Tris-HCl, 10 mM 
(NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton X-100, pH 8.8 @ 25OC, and 2 mM MnCl2 
for 10 minutes at 65 OC. (5) washing with water, 1X SPSC buffer, and water again. (6) cleavage 
with 10 mM THP for 10 minutes at 65 OC. (7) washing with water, 1X SPSC buffer, and water 
again. (8) scanning air dried slides to confirm the cleavage. The above was carried out 6 times to 
obtain the raw image intensity readings shown in the bar graph at the bottom of Figure 3-18 for 















3.5.2. Four-Color SBS Using a Combination of Two 3’-O-SS-Cleavable Fluorescent 
Modified NRTs and Two 3’-O-SS-Cleavable Anchor Modified NRTs with their 
Corresponding Dye Labeled Binding Molecules on a Chip 
 
To demonstrate the scarless SBS on a chip by using the 3’-O-SS-cleavable fluorescent/anchor 
modified NRTs as substrates, two 3’-O-SS-cleavable fluorescent nucleotide analogues and two 3’-
O-SS-cleavable anchor nucleotide analogues have been used to examine the sequencing procedure 
on the chip. The experiment to obtain the successive sequence was performed by addition of 3’-
O-ROX-PEG4-SS-dATP, 3’-O-BodipyFL-PEG4-SS-dTTP, 3’-O-Biotin-SS-dCTP, 3’-O-TCO-
PEG4-SS-dGTP, 3’-O-tert-Butyl-SS-dATP, 3’-O-tert-Butyl-SS-dTTP, 3’-O-tert-Butyl-SS-dCTP, 
3’-O-tert-Butyl-SS-dGTP, TherminatorTM IX DNA polymerase, and cofactor ions to the 
immobilized primed DNA template. The sequencing procedure (see Scheme 3-3) enables the 
incorporation of the complementary nucleotide analogue to the growing DNA strand to terminate 
DNA synthesis. After washing to remove unused nucleotide analogues and polymerase, the single 
base extended products were scanned to obtain the fluorescent images from 3’-O-ROX-PEG4-SS-
dATP and 3’-O-BodipyFL-PEG4-SS-dTTP extended products. Next, the dye labeled binding 
molecules (tetrazine-PEG4-TAMRA and streptavidin-Cy5) were added to the DNA extension 
products, which will specifically connect with the two unique anchor moieties (TCO and Biotin) 
on DNA extension products. After washing away unbound binding molecules, the single base 
extended products were scanned to obtain the fluorescent images from the bound tetrazine-PEG4-
TAMRA and streptavidin-Cy5 for identifying 3’-O-TCO-PEG4-SS-dGTP and 3’-O-Biotin-SS-
dCTP extended products. In the following chase step, re-addition of the four 3’-O-tert-Butyl-SS-
dNTPs and polymerase to the immobilized primed DNA template assures the incorporation of the 
complementary 3’-O-tert-Butyl-SS-dNTPs analogue to the growing DNA strands that were not 
extended with one of the fluorescent or anchor labeled nucleotide analogues. Therefore, the 
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growing DNA strands are terminated with one of four nucleotide analogues, either fluorescent or 
anchor labeled analogues or the same one of the four nucleotide analogues without fluorescent or 
anchor. This chase step may be removed from the scheme if all growing DNA strands efficiently 
extended using an appropriate ratio of the 8 NRTs in the initial extension step. After washing away 
unused nucleotides and DNA polymerase, treatment with THP regenerated the 3’-OH of the 
growing DNA strand and the resulting product was ready for the next cycle. After washing away 
the cleaved moieties and reagents, the cleavage products were scanned to obtain the background 
fluorescent images to confirm the cleavage. 
 
SBS results were obtained over seven cycles using the approach combining of two 3’-O-SS-
cleavable fluorescent modified NRTs and two 3’-O-SS-cleavable anchor modified NRTs (see 
Figure 3-19). The two continuous sequences of the first seven bases (based on fluorescent signal 
detection) were correctly identified as CATCAAG and ATTAGAG. In each SBS cycle, the 
fluorescent signal for the correct read was high enough compared with other incorrect (background) 
signals. Although the signals for the sequence read were unambiguous, further optimization might 
result in lower background signals. The successful labeling of the 3’-anchor modified nucleotide 
analogue extension products and sequencing over 7 continuous SBS cycles indicates that the novel 
design of 3’-O-SS-cleavable fluorescent modified NRTs and 3’-O-SS-cleavable anchor modified 







Scheme 3-3. Scheme of scarless SBS using a combination of two 3’-O-SS-cleavable fluorescent 
modified NRTs (3’-O-ROX-PEG4-SS-dATP and 3’-O-BodipyFL-PEG4-SS-dTTP) and two 3’-O-
SS-cleavable anchor modified NRTs (3’-O-Biotin-SS-dCTP and 3’-O-TCO-PEG4-SS-dGTP) to 
perform DNA SBS. Four 3’-O-tert-Butyl-SS-dNTPs (3’-O-tert-Butyl-SS-dATP, 3’-O-tert-Butyl-
SS-dTTP, 3’-O-tert-Butyl-SS-dCTP, and 3’-O-tert-Butyl-SS-dGTP) also were added in both the 
extension and chase steps. (Step 1) addition of four nucleotide analogues 3’-O-ROX-PEG4-SS-
dATP, 3’-O-BodipyFL-PEG4-SS-dTTP, 3’-O-Biotin-SS-dCTP, and 3’-O-TCO-PEG4-SS-dGTP, 
along with the four 3’-O-tert-Butyl-SS-dNTPs to extend the growing DNA strand to terminate 
DNA synthesis; (Step 2) washing away unused nucleotides and DNA polymerase; (Step 3) 
imaging the immobilized DNA extension products to determine the incorporated nucleotides; 
(Step 4) labeling with the dye labeled binding molecules (TAMRA labeled tetrazine and Cy5 
labeled streptavidin) to specifically connect with the two unique anchor (TCO and Biotin) moieties; 
(Step 5) washing away unused binding molecules; (Step 6) imaging the immobilized DNA 
extension products to determine incorporated nucleotides, which were dye labeled in Step 5; (Step 
7) chase with 3’-O-tert-Butyl-SS-dATP, 3’-O-tert-Butyl-SS-dTTP, 3’-O-tert-Butyl-SS-dCTP, and 
3’-O-tert-Butyl-SS-dGTP to extend the growing strands that were not extended with one of the 
fluorescent or anchor labeled dNTPs in Step 1; (Step 8) washing away unused nucleotides and 
DNA polymerase; (Step 9) cleavage of the SS linker with THP to regenerate the 3’-OH of the 
growing DNA strand; (Step 10) washing away the cleaved moieties and reagents; (Step 11) 





Figure 3-19. Seven cycles of SBS obtained using 3’-O-ROX-PEG4-SS-dATP, 3’-O-BodipyFL-
PEG4-SS-dTTP, 3’-O-Biotin-SS-dCTP, 3’-O-TCO-PEG4-SS-dGTP, 3’-O-tert-Butyl-SS-dATP, 
3’-O-tert-Butyl-SS-dTTP, 3’-O-tert-Butyl-SS-dCTP, 3’-O-tert-Butyl-SS-dGTP, tetrazine-PEG4-
TAMRA and streptavidin-Cy5. The signals correctly identified the sequence 5’-CATCAAG-3’ 
(top) and 5’-ATTAGAG-3’ (bottom). In each cycle, the fluorescent signals of BodipyFL and ROX 
were collected from the first imaging (step 3) (E), and that of TAMRA and Cy5 were collected 
from the second imaging (step 6) (L), although all 4 channels ware assessed in each imaging sep. 
The highest intensity of these four collected signals was identified as the sequence read. The 
fluorescent signals of cleavage were collected from the third imaging (step 11) (C). 
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Demonstration of SBS Using a Combination of Two 3’-O-SS-Cleavable Fluorescent Modified 
NRTs and Two 3’-O-SS-Cleavable Anchor Modified NRTs with their Corresponding 
Fluorescent Anchor Binding Molecules on an Immobilized DNA Primer-Loop Template  
Using the looped priming template shown schematically at the top of Figure 3-19, reactions were 
carried out as in the protocol for Scheme 3-3. 5’-NH2-modified template was immobilized on NHS 
ester-modified slides from Surmodics. Each cycle was carried out as follows: (1) extension with 
60 l of 0.4 M 3'-O-ROX-PEG4-SS-dATP, 0.4 M 3'-O-BodipyFL-PEG4-SS-dTTP, 0.4 M 3'-
O-TCO-PEG4-SS-dGTP, 0.4 M 3'-O-Biotin-SS-dCTP, 0.05 M 3’-O-tert-Butyl-SS-dATP, 0.05 
M 3’-O-tert-Butyl-SS-dTTP, 0.05 M 3’-O-tert-Butyl-SS-dCTP, 0.05 M 3’-O-tert-Butyl-SS-
dGTP, 6 units of TherminatorTM IX DNA Polymerase (NEB), in 1X Thermo Pol buffer containing 
20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, 0.1% Triton X-100, pH 8.8 @ 
25OC, and 2 mM MnCl2 for 10 minutes at 65 OC. (2) washing with water, 1X SPSC buffer, and 
water again. (3) scanning air dried slides at 488 nm (ex = 488 nm; em = 522 nm), 543 nm (ex = 
546 nm; em = 570 nm), 594 nm (ex = 594 nm; em = 614 nm) and 633 nm (ex = 633 nm; em = 
670 nm) (ScanArray® Express, PerkinElmerTM) to record fluorescence intensity of the spots. (4) 
labeling with 60 l of 10 M Tetrazine-PEG4-TAMRA, 4 M Streptavidin-Cy5, 1X PBS, pH 7.4 
for 15 minutes at 37 OC. (5) washing with water, 1X SPSC buffer, and water again. (6) scanning 
air dried slides at 488 nm (ex = 488 nm; em = 522 nm), 543 nm (ex = 546 nm; em = 570 nm), 
594 nm (ex = 594 nm; em = 614 nm) and 633 nm (ex = 633 nm; em = 670 nm) (ScanArray® 
Express, PerkinElmerTM) to record fluorescence intensity of the spots. (7) chase with 60 l of 4 
M each of the four 3’-O-tert-Butyl-SS-dNTPs, 6 units of TherminatorTM IX DNA Polymerase 
(NEB), in 1X Thermo Pol buffer containing 20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl, 2 
mM MgSO4, 0.1% Triton X-100, pH 8.8 @ 25OC, and 2 mM MnCl2 for 10 minutes at 65 OC. (8) 
washing with water, 1X SPSC buffer, and water again. (9) cleavage with 10 mM THP for 10 
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minutes at 65 OC. (10) washing with water, 1X SPSC buffer, and water again. (11) scanning air 
dried slides to confirm the cleavage. The above was carried out 7 times to obtain the raw image 
intensity readings shown in the bar graph at the bottom of Figure 3-19 for the first seven bases of 
the extended primers. 
 
3.6. Summary 
The novel synthesized 3’-O-SS-cleavable fluorescent/anchor modified nucleotide reversible 
terminators have been investigated to develop a protocol for scarless DNA SBS through 
incorporation reactions in solution and on a chip. In solution, the incorporation efficiency of 3’-O-
Fluorescent/Anchor-PEG4-SS-dNTPs is much higher than 3’-O-Fluorescent/Anchor-SS-dNTPs in 
competitive reactions, suggesting that the PEG linker could extend a bulky fluorescent group away 
from the reaction sites in the polymerase ternary complex. Also, the incorporation efficiency of 
the 3’-O-modified nucleotide without a bulky moiety (3’-O-tert-Butyl-SS-dNTP analogue) is 
much higher than one with a PEG linker, as assessed by the higher incorporation efficiency of the 
unlabeled nucleotide analogues despite their lower proportion in the mixture relative to the 3’-O-
Fluorescent/Anchor-PEG4-SS-dNTPs. To further understand the potential of using the 
combination of 3’-O-SS-cleavable fluorescent and 3’-O-SS-cleavable anchor modified nucleotide 
reversible terminators for SBS, a set of four of the 3’-O-SS-cleavable fluorescent/anchor 
nucleotide analogues (3’-O-ROX-PEG4-SS-dATP, 3’-O-BodipyFL-SS-dTTP, 3'-O-Biotin-SS-
dCTP, and 3'-O-TCO-SS-dGTP) was selected and applied to successfully obtain a continuous four 
base sequence in solution. 
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Moreover, to use the 3’-O-SS-cleavable fluorescent nucleotide analogues to conduct SBS on a 
chip, the 3’-O-ROX-PEG4-SS-dATP and 3’-O-BodipyFL-PEG4-SS-dTTP as well as 3’-O-tert-
Butyl-SS-dNTPs were applied cooperatively to extend the surface-immobilized DNA self-priming 
template, resulting in 6 base SBS reads as proof-of-principle of scarless SBS with two 3’-O-SS-
fluorescent modified NRTs. To further include the 3’-O-SS-cleavable anchor nucleotide analogues 
for SBS on a chip, the labeling of 3’-O-TCO-PEG4-SS-dGTP with tetrazine-PEG4-TAMRA as 
well as the labeling of 3’-O-Biotin-SS-dCTP with streptavidin-Cy5 were successfully 
demonstrated on a chip. With the above support, the 3’-O-SS-cleavable fluorescent/anchor 
modified NRTs (3’-O-ROX-PEG4-SS-dATP, 3’-O-BodipyFL-PEG4-SS-dTTP, 3’-O-Biotin-SS-
dCTP, and 3’-O-TCO-PEG4-SS-dGTP) were used to successfully demonstrate extension of the 
surface-immobilized DNA self-priming template, resulting in 7 base SBS reads for two different 
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Chapter 4 Summary and Prospective  
 
In the past few decades, a rapid advancement of sequencing techniques from the expensive and 
laborious Sanger sequencing to next-generation, or short-read massively parallel sequencing 
methods has taken place. Numerous scientists have dedicated themselves to the development and 
improvement of DNA sequencing techniques, leading to a significant acceleration in sequencing 
speed and drop in costs. The advanced next-generation sequencing methods have been extensively 
applied in many areas, including human genomics and genetics, microbial genomics, agriculture, 
diagnosis and therapy, and many more. 
 
To continuously improve the sequencing by synthesis technology, we have constructed and 
successfully demonstrated scarless SBS using novel designed and synthesized 3’ reversibly 
fluorescent/anchor labeled nucleotides. The 3’-O-SS-cleavable fluorescent/anchor modified NRTs 
are able to form the natural DNA strand after each cycle of sequencing reaction, potentially 
resulting in longer sequencing read lengths.  The PEG-extended linker at the 3’-O position of 
nucleotides shifts bulky moieties away from the reaction sites of the DNA polymerase complex, 
thereby increasing the incorporation efficiency. More important, the extended primers using 3’-O-
SS-cleavable anchor modified NRTs become accessible to fluorescent labeled binding molecules, 
allowing them to be specifically connected to the corresponding anchor moiety at the 3’ end of the 




As a further application of the SBS method with 3’-O-SS-cleavable anchor modified NRTs, 
the potential for two color sequencing will be explored. This would have the advantage of reducing 
instrument size and cost. For example, streptavidin and tetrazine binding molecules can be labeled 
with the same fluorescent reporters as the 3’-O-SS-cleavable fluorescent modified NRTs, e.g., 
tetrazine-BodipyFL and streptavidin-ROX. In the sequencing procedure, the same combination of 
3’-O-SS-cleavable fluorescent/anchor modified NRTs could be used following the same SBS 
scheme with two imaging steps for the extension product identification.  With these two imaging 
steps, two colors are sufficient to identify all four nucleotides. If one of the two 3’-O-SS-cleavable 
fluorescent modified NRTs are incorporated, a fluorescent signal would be obtained in the imaging 
after the extension step; or if one of the two 3’-O-SS-cleavable anchor modified NRTs are 
incorporated, the fluorescent signal would only be obtained in the imaging step after the adding 
dye-labeled binding molecules. In this design, the use of only two fluorescent reporters and two 
imaging steps allows the conclusive determination of the incorporated base in each cycle.  
 
During the development of DNA sequencing over the last few decades, approaches producing 
high-throughput, long read-length with high accuracy are key to achieving the goal of cheaper and 
faster sequencing technology. Our new proof-of-principle scarless SBS method using novel design 
3’-O-SS-cleavable fluorescent/anchor modified NRTs provides a mechanism for moving 









Figure A1. 1H NMR of Compound (1). 
 




Figure A3. 19F NMR of Compound (1). 
 




Figure A5. 13C NMR of Compound (2). 
 




Figure A7. 13C NMR of Compound (3). 
 




Figure A9. 1H NMR of Compound (4). 
 




Figure A11. 19F NMR of Compound (4). 
 





Figure A13. 13C NMR of Compound (8). 
 




Figure A15. 13C NMR of Compound (10). 
 




Figure A17. 1H NMR of Compound (14). 
 




Figure A19. 1H NMR of Compound (15). 
 




Figure A21. 1H NMR of Compound (17). 
 




Figure A23. 19F NMR of Compound (17). 
 




Figure A25. 13C NMR of Compound (21). 
 




Figure A27. 13C NMR of Compound (22). 
 




Figure A29. 13C NMR of Compound (23). 
 




Figure A31. 13C NMR of Compound (25). 
 




Figure A33. HRMS of Compound (5). 
 




Figure A35. MALDI-TOF MS of Compound (7). 
 




Figure A37. MALDI-TOF MS of Compound (12). 
 




Figure A39. HRMS of Compound (18). 
 




Figure A41. HRMS of Compound (20). 
 




Figure A43. MALDI-TOF MS of Compound (27). 
 
Figure A44. HRMS of Compound (28). 
